<SEC-DOCUMENT>0001683168-18-001108.txt : 20180430
<SEC-HEADER>0001683168-18-001108.hdr.sgml : 20180430
<ACCEPTANCE-DATETIME>20180430080219
ACCESSION NUMBER:		0001683168-18-001108
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20180614
FILED AS OF DATE:		20180430
DATE AS OF CHANGE:		20180430
EFFECTIVENESS DATE:		20180430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIFEWAY FOODS INC
		CENTRAL INDEX KEY:			0000814586
		STANDARD INDUSTRIAL CLASSIFICATION:	DAIRY PRODUCTS [2020]
		IRS NUMBER:				363442829
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17363
		FILM NUMBER:		18786764

	BUSINESS ADDRESS:	
		STREET 1:		6431 W OAKTON
		CITY:			MORTON GROVE
		STATE:			IL
		ZIP:			60053
		BUSINESS PHONE:		847-967-1010

	MAIL ADDRESS:	
		STREET 1:		6431 W OAKTON
		CITY:			MORTON GROVE
		STATE:			IL
		ZIP:			60053
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>lway_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-top: Black 4.5pt double"><B>UNITED
STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Rule 14a-101)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proxy Statement Pursuant to Section 14(a)
of the Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by the Registrant <FONT STYLE="font-family: Wingdings">&thorn;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by a Party other than the Registrant <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="width: 0in"></TD><TD STYLE="text-align: justify">Preliminary Proxy Statement</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="width: 0in"></TD><TD STYLE="text-align: justify"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&thorn;</FONT></TD><TD STYLE="width: 0in"></TD><TD STYLE="text-align: justify">Definitive Proxy Statement</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="width: 0in"></TD><TD STYLE="text-align: justify">Definitive Additional Materials</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="width: 0in"></TD><TD STYLE="text-align: justify">Soliciting Material Pursuant to &sect;240.14a-12</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIFEWAY FOODS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Registrant as Specified In Its
Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">__________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check the appropriate box)</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&thorn;</FONT></TD><TD STYLE="width: 0in"></TD><TD STYLE="text-align: justify">No fee required.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="width: 0in"></TD><TD STYLE="text-align: justify">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD>
</TR></TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 27pt">(1)</TD>
    <TD>Title
of each class of securities to which transaction applies:</TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 27pt">(2)</TD>
    <TD>Aggregate
number of securities to which transaction applies:</TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 27pt">(3)</TD><TD>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on
which the filing fee is calculated and state how it was determined):</TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 27pt">(4)</TD>
    <TD>Proposed
maximum aggregate value of transaction:</TD></TR>
</TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 27pt">(5)</TD>
    <TD>Total
fee paid:</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="width: 0in"></TD><TD STYLE="text-align: justify">Fee paid previously with preliminary materials.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD>Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and
the date of its filing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amount
Previously Paid:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form,
Schedule or Registration Statement No.:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filing
Party:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(4)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Date
Filed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIFEWAY FOODS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>To Be Held On June 14, 2018</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Fellow Shareholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We invite you to attend the 2018 Annual
Meeting of Shareholders of Lifeway Foods, Inc., an Illinois corporation (&ldquo;Lifeway,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo;
or the &ldquo;Company&rdquo;), which will be held on Thursday, June 14, 2018, at 2:00 p.m., local time (the &ldquo;Annual Meeting&rdquo;),
at the Holiday Inn, 5300 W. Touhy Avenue, Skokie, Illinois 60077. At the Annual Meeting, you will be asked to vote on the following
proposals (as more fully described in the Proxy Statement accompanying this Notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">To elect 8 members of Lifeway&rsquo;s Board of Directors to serve until the 2019 Annual Meeting
of Shareholders (or until successors are elected or directors resign or are removed).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">To ratify the appointment of Mayer Hoffman McCann P. C. as our independent registered public accounting
firm for the fiscal year ending December 31, 2018.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">To transact such other business as may properly come before the Annual Meeting or any adjournment
thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Only shareholders of record at the close
of business on April 13, 2018 are entitled to notice of and to vote at the Annual Meeting or any adjournment thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">YOUR VOTE IS VERY IMPORTANT. WE HOPE YOU
WILL ATTEND THIS ANNUAL MEETING IN PERSON. HOWEVER, REGARDLESS OF WHETHER YOU PLAN TO ATTEND THE MEETING, PLEASE PROMPTLY VOTE
YOUR SHARES VIA THE INTERNET OR THE TOLL-FREE NUMBER AS DESCRIBED IN THE ENCLOSED MATERIALS. IF YOU RECEIVED A PROXY CARD BY MAIL,
PLEASE SIGN, DATE AND RETURN IT IN THE ENVELOPE PROVIDED. IF YOU RECEIVED MORE THAN ONE PROXY CARD, IT IS AN INDICATION THAT YOUR
SHARES ARE REGISTERED IN MORE THAN ONE ACCOUNT. PLEASE COMPLETE, DATE, SIGN AND RETURN <U>EACH</U> PROXY CARD YOU RECEIVE. IF YOU
ATTEND THE ANNUAL MEETING AND VOTE IN PERSON, YOUR VOTE BY PROXY WILL NOT BE USED.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">BY ORDER OF THE BOARD OF DIRECTORS</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><U>/s/ Douglas A. Hass</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Douglas A. Hass</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">General Counsel and Assistant Corporate Secretary</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chicago, Illinois</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: <FONT STYLE="font-family: Times New Roman, Times, Serif">April
30, 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIFEWAY FOODS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>6431 W. Oakton</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Morton Grove, Illinois 60053</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2018 ANNUAL MEETING OF SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>June 14, 2018</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The enclosed proxy is solicited by the
Board of Directors (the &ldquo;Board&rdquo;) of LIFEWAY FOODS, INC. (&ldquo;Lifeway,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo;
or the &ldquo;Company&rdquo;) for use at Lifeway&rsquo;s 2018 Annual Meeting of Shareholders to be held on Thursday, June 14, 2018,
at 2:00 p.m., local time, or at any adjournment thereof (the &ldquo;Annual Meeting&rdquo;). The Annual Meeting will be held at
the Holiday Inn, 5300 W. Touhy Avenue, Skokie, Illinois 60077. Lifeway&rsquo;s telephone number is (847) 967-1010. This Proxy Statement
and accompanying proxy materials are first being mailed to shareholders on April 30, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>What Am I Voting On?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You will be entitled to vote on the following
proposals at the Annual Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The election of the director nominees named herein to serve on our Board for a term of office expiring
at the 2019 Annual Meeting of Shareholders or until their successors are elected and duly qualified (Proposal One);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The ratification of the selection of Mayer Hoffman McCann P.C. as our independent registered public
accounting firm for the fiscal year ending December 31, 2018 (Proposal Two).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Any other business as may properly come before the Annual Meeting or any continuation, postponement,
or adjournment thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Who Can Vote?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The Board has set April 13, 2018 as the Record Date for the Annual Meeting. You are entitled to
notice and to vote if you were a holder of record of Common Stock as of the close of business on April 13, 2018. Your shares may
be voted at the Annual Meeting only if you are present in person or your shares are represented by a valid proxy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>YOUR VOTE IS VERY IMPORTANT. PLEASE SUBMIT
YOUR PROXY EVEN IF YOU PLAN TO ATTEND THE ANNUAL MEETING.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholders of record at the close of
business on April 13, 2018 (the &ldquo;Record Date&rdquo;) are entitled to notice of and to vote at the Annual Meeting. You can
obtain directions to the Annual Meeting by calling Lifeway at (847) 967-1010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each holder of Common Stock is entitled
to one vote for each share of Common Stock held as of the Record Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may vote by attending the Annual Meeting
and voting in person or you may vote by submitting a proxy. The method of voting by proxy differs&nbsp;for shares held as a record
holder and shares held in &ldquo;street name.&rdquo; If you hold your shares of Common Stock as a record holder, you may vote your
shares over the Internet or by phone by following the instructions on the proxy card or by completing, dating, and signing the
proxy card that you receive, and by promptly returning the proxy card via mail in the envelope provided. If you hold your shares
of Common Stock in street name, which means that your shares are held of record by a broker, bank, or other nominee, you will receive
instructions from your broker, bank, or other nominee that includes instructions on how to vote your shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a stockholder
of record, you may vote your shares as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To vote through the Internet, go to http://www.proxyvote.com to complete an electronic proxy card.
You will be asked to provide the company number and control number from the proxy card. Your Internet vote must be received by
11:59 p.m., Eastern Time on June 13, 2018 to be counted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To vote by phone, call (800) 690-6903 and follow the pre-recorded instructions. You will be asked
to provide the company number and control number from the proxy card. Your telephone vote must be received by 11:59 p.m., Eastern
Time on June 13, 2018 to be counted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">To vote using the proxy card delivered to you, simply complete, sign, and date the proxy card and
return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote
your shares as you direct.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>QUORUM; ABSTENTIONS; BROKER NON-VOTES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the Record Date, 15,877,851 shares
of Lifeway&rsquo;s Common Stock, no par value, were issued and outstanding. We have no other class of securities outstanding. A
majority of the aggregate voting power of the outstanding shares of Common Stock as of the Record Date must be present, in person
or by proxy, at the Annual Meeting in order to have the required quorum for the transaction of business. If the aggregate voting
power of the shares of Common Stock present, in person and by proxy, at the Annual Meeting does not constitute the required quorum,
we may adjourn the Annual Meeting to a subsequent date for the purpose of obtaining a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares of Common Stock that are voted &ldquo;FOR,&rdquo;
&ldquo;WITHHOLD,&rdquo; or &ldquo;AGAINST&rdquo; on a matter are treated both as being present for purposes of establishing a quorum
and as shares entitled to vote at the Annual Meeting (the &ldquo;Votes Cast&rdquo;) with respect to such matter. Abstentions and
Broker Non-Votes (i.e., shares of Common Stock held as of the Record Date by brokers or other custodians as to which the beneficial
owners have given no voting instructions) will be counted for purposes of determining the presence or absence of a quorum for the
transaction of business, but will not be counted for purposes of determining the number of Votes Cast with respect to a particular
proposal on which the broker has expressly not voted. Abstentions and Broker Non-Votes, therefore, will have no effect on proposals
that require a plurality or majority of Votes Cast for approval, but will have the same effect as a vote &ldquo;against&rdquo;
proposals requiring any percentage of the outstanding voting securities for approval. Brokers do not have discretionary authority
to vote on the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DEADLINE FOR RECEIPT OF SHAREHOLDER PROPOSALS
TO BE PRESENTED AT OUR NEXT ANNUAL MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order for any shareholder proposal submitted
pursuant to Rule 14a-8 promulgated under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), to be
included in our Proxy Statement to be issued in connection with the 2019 Annual Meeting of Shareholders, we must receive such shareholder
proposals no later than December 31, 2018. Any such shareholder proposal submitted, including any accompanying supporting statement,
may not exceed 500 words, per Rule 14a-8(d) of the Exchange Act. All shareholder proposals must be made in writing and addressed
to Lifeway&rsquo;s Secretary or Assistant Secretary, c/o Lifeway Foods, Legal Department, 6101 West Gross Point Road, Niles, Illinois
60714.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY CARD AND REVOCABILITY OF PROXY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may vote by completing and mailing
the enclosed proxy card. As a shareholder of record, if you sign the proxy card but do not specify how you want your shares to
be voted, your shares will be voted by the proxy holders named in the enclosed proxy as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">FOR the election of the director nominees named herein (Proposal One), unless you are a record
holder of your shares and specifically withhold authority to vote for one or more of the director nominees. If you hold your shares
through a broker in &ldquo;street name,&rdquo; your broker will not be allowed to vote on Proposal One unless you direct your broker
as to such vote.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">FOR ratifying the appointment of Mayer Hoffman McCann P.C. as our independent registered public
accounting firm for the fiscal year ending December 31, 2018 (Proposal Two).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In their discretion, the proxy holders
named in the enclosed proxy are authorized to vote on any other matters that may properly come before the Annual Meeting and at
any continuation, postponement or adjournment thereof. The Board knows of no other items of business as of the date of this Proxy
Statement that will be presented for consideration at the Annual Meeting other than those described in this Proxy Statement. In
addition, we did not receive any shareholder proposals or nominations on a timely basis, so no such matters may be brought to a
vote at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you vote by proxy, you may revoke that
proxy or change your vote at any time before it is voted at the Annual Meeting. Shareholders of record may revoke a proxy or change
their vote prior to the Annual Meeting by delivering to Lifeway&rsquo;s Secretary or Assistant Secretary, c/o Legal Department,
Lifeway Foods, 6101 West Gross Point Road, Niles, Illinois 60714, a written notice of revocation, a duly executed proxy bearing
a later date, or by attending the Annual Meeting and voting in person. Attending the Annual Meeting will not, by itself, revoke
a proxy. If your shares are held in the name of a bank, broker, or other nominee, you may change your vote by submitting new voting
instructions to your bank, broker, or other nominee. Please note that if your shares are held of record by a bank, broker, or other
nominee, and you decide to attend and vote at the Annual Meeting, your vote in person at the Annual Meeting will not be effective
unless you present a legal proxy issued in your name from the record holder (your bank, broker, or other nominee).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DISSENTERS&rsquo; RIGHT OF APPRAISAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Illinois General Corporation Law
and Lifeway&rsquo;s Certificate of Incorporation, shareholders are not entitled to any appraisal or similar rights of dissenters
with respect to any of the proposals to be acted on at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AVAILABILITY OF PROXY MATERIALS AND SOLICITATION
OF PROXIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway will bear the entire cost of solicitation
of proxies, including preparation, assembly, printing, and mailing of this Proxy Statement, the accompanying annual report and
proxy card and any additional information furnished to shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may supplement the original solicitation
of proxies by mail by certain of our directors, executive officers, and regular employees, without additional compensation, in
person, or by telephone, e-mail, or facsimile. We will not pay any additional compensation to directors, executive officers, or
regular employees for such services. We may reimburse brokerage firms, banks, custodians, and other persons representing beneficial
owners of shares of Common Stock for their reasonable out-of-pocket expenses in forwarding the solicitation materials to those
beneficial owners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have adopted a procedure approved by
the SEC called &ldquo;householding.&rdquo; Under this procedure, multiple shareholders who share the same last name and address
will receive only one copy of the annual proxy materials, unless they notify us that they wish to continue receiving multiple copies.
We have undertaken householding to reduce our printing costs and postage fees. If you currently receive multiple copies of the
proxy materials at the same address and wish to opt in to householding, or if you currently do <U>not</U> receive multiple copies
and wish to opt out of householding, you may notify us in writing or by telephone. Lifeway will also promptly deliver an additional
copy of the proxy materials to any shareholder who requests one. Any such request should be directed to Lifeway&rsquo;s Secretary
or Assistant Secretary, c/o Legal Department, Lifeway Foods, 6101 West Gross Point Road, Niles, Illinois 60714, (847) 967-1010.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Attending the Annual Meeting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Admission to the Annual Meeting is limited
to shareholders as of the close of business on the Record Date with proof of ownership of Lifeway&rsquo;s Common Stock, as well
as valid government-issued photo identification, such as a valid driver&rsquo;s license or passport. If your shares are held in
the name of a broker, bank, or other nominee and you plan to attend the Annual Meeting, you must present proof of your ownership
of stock, such as a bank or brokerage account statement, to be admitted to the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL ONE<BR>
ELECTION OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board currently consists of eight (8)
directors, all of whom have been nominated for re-election. Shareholders and their proxies are being asked to vote on the eight
(8) persons nominated for the Board, as set forth below. Each nominee has consented to being named as a nominee for election as
a director and has agreed to serve if elected. At the Annual Meeting, directors will be elected to serve a term of office expiring
at the 2019 Annual Meeting of Shareholders or until their successors are elected and duly qualified, subject, however, to their
prior death, disability, resignation, retirement, disqualification, or removal from office.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain information about the nominees
to the Board is set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LUDMILA SMOLYANSKY, 68, was appointed as
a Director by the Board to fill a vacancy created by an increase of the maximum number of Directors up to seven and unanimously
elected as the Chairperson of the Board in November 2002. Mrs. Smolyansky has been the operator of several independent delicatessen
and gourmet food distributorship businesses, and imported food distributorships. Mrs. Smolyansky and Michael Smolyansky founded
Lifeway and Mrs. Smolyansky served as our General Manager. In 2010, Mrs. Smolyansky retired as a Lifeway employee and has continued
to serve Lifeway as its Chairperson of the Board since 2002 and as a consultant since 2011. Mrs. Smolyansky holds no other directorships
in any other reporting company. Mrs. Smolyansky is the mother of Julie Smolyansky (the President, Chief Executive Officer, and
a Director of the Company) and Edward Smolyansky (the Chief Operating Officer, Treasurer, Secretary, and a Director of the Company).
Mrs. Smolyansky brings many years of food industry experience, historical perspective, and operational expertise to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">JULIE SMOLYANSKY, 43, was appointed as
a Director and elected President and Chief Executive Officer of Lifeway by the Board of Directors to fill the vacancies in those
positions created by the death of her father, Michael Smolyansky, in June 2002. She is a graduate with a bachelor&rsquo;s degree
from the University of Illinois at Chicago. Prior to her appointment, Ms. Smolyansky spent six years as Lifeway&rsquo;s Director
of Sales and Marketing. Ms. Smolyansky also served as Lifeway&rsquo;s Chief Financial Officer and Treasurer from 2002 to 2004.
She holds no other directorships in any other reporting company. Ms. Smolyansky is the daughter of Ludmila Smolyansky (the Chairperson
of the Board), and brother of Edward Smolyansky (the Chief Operating Officer, Treasurer, Secretary, and a Director of the Company).
The significant knowledge base and operational expertise she has acquired by serving the Company as a senior executive for over
twenty years qualify her to continue to serve on the Board. Ms. Smolyansky&rsquo;s family maintains a controlling interest in the
Company, and the Board believes it is appropriate to provide for continuity of the representation of the Smolyansky family on the
Board as a component of our succession planning strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EDWARD SMOLYANSKY, 38, was elected as a
Director in June 2017 and is Lifeway&rsquo;s Chief Operating Officer, Treasurer, and Secretary. Mr. Smolyansky was appointed as
Chief Financial and Accounting Officer and Treasurer of Lifeway in November 2004 and appointed as the Chief Operating Officer and
Secretary in 2012. He resigned his titles as Chief Financial Officer on January 1, 2016 and as Chief Accounting Officer on August
8, 2016. He also served as Lifeway&rsquo;s Controller from June 2002 until 2004. He received his bacherlor&rsquo;s degree in finance
from Loyola University of Chicago in December 2001. He holds no other directorships in any other reporting company. Mr. Smolyansky
is the brother of President and CEO Julie Smolyansky and the son of Lifeway&rsquo;s Chairperson of the Board Ludmila Smolyansky.
Mr. Smolyansky&rsquo;s role, and knowledge acquired, serving the Company in a senior executive capacity since 2002 qualify him
to continue to serve on the Board. Mr. Smolyansky&rsquo;s family maintains a controlling interest in the Company, and the Board
believes it is appropriate to provide for continuity of the representation of the Smolyansky family on the Board as a component
of our succession planning strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">POL SIKAR, 70, has been a Lifeway Director
since the Company&rsquo;s inception in February 1986. He holds a master&rsquo;s degree from the Odessa State Institute of Civil
Engineering in Russia. For more than 40 years, he has been President and a major shareholder of Montrose Glass &amp; Mirror Co.,
a company providing glass and mirror products to the wholesale and retail trade in the greater Chicago area. Mr. Sikar devotes
as much time as necessary to the business of the Company and currently holds no other directorships in any other reporting company.
Mr. Sikar brings a historical perspective to the Board along with executive and entrepreneurial experiences that provide Lifeway
with insights into operational and strategic planning, and financial matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RENZO BERNARDI, 80, was elected as a Director
of Lifeway in 1994. Mr. Bernardi is the president and founder of Renzo &amp; Sons, Inc., a dairy and food service company which
has been in business since 1969 (formerly, Renzo-Milk Distribution Systems). He has nearly 50 years of experience in the dairy
distribution industry. Mr. Bernardi is a graduate of Instituto Tecnico E Commerciale of Macomer, Sardinia. Mr. Bernardi devotes
as much time as necessary to the business of the Company and currently holds no other directorships in any other reporting company.
Mr. Bernardi brings deep industry experience and a historical perspective to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PAUL LEE, 43, was elected as a Director
of Lifeway to fill a vacancy on the Board of Directors in July 2012. Mr. Lee is currently CEO of Builders VC, which he co-founded
in 2015 as Roniin LLC. From 2010 to 2015, Mr. Lee was a General Partner at Lightbank LLC and was a founding member and Senior Vice
President at the Peacock Equity Fund. Mr. Lee brings financial and strategic experience to the Company&rsquo;s Board of Directors.
He holds a MBA degree in finance from UCLA. Mr. Lee devotes as much time as necessary to the business of the Company and currently
holds no other directorships in any other reporting company. Mr. Lee&rsquo;s brings to the Board significant financial expertise
developed through his experience in a range of industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">JASON SCHER, 43, was elected as a Director
of Lifeway to fill a vacancy on the Board of Directors in July 2012. Since 2016, he has been advising and consulting for several
real estate development, hospitality, and consumer packaged goods companies in Chicago and California. From 2004 until 2016, Mr.
Scher was the Chief Operating Officer of Vosges Haut-Chocolat, a leading manufacturer and seller of super premium chocolate confections
in the U.S. Additionally, he is currently a Managing Member of South Shore Developers Group, a real estate development company
focused on affordable housing in the Chicago area. From 2000 to 2004, Mr. Scher served as a principal in RP3 Development, a New
York based construction management and development company that performed work nationwide. Mr. Scher started his career with XandO
coffee bar/COSI Sandwich Bar in their real estate and construction group. His strong leadership has been instrumental in the growth
and development of the businesses that he worked in over the years. Mr. Scher devotes as much time as necessary to Lifeway&rsquo;s
business and currently holds no other directorships in any other reporting company. Mr. Scher brings manufacturing, financial,
and strategic experience to the Company&rsquo;s board of directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LAURENT MARCEL, 46, was appointed as a
Director of Lifeway to fill a vacancy on the Board on January 1, 2018. Mr. Marcel is a French citizen. He is a Director of Harmless
Harvest, Inc. and Michel et Augustin, SAS and was formerly a Director of Danone North America Public Benefit Corporation. Mr. Marcel
is serving as the interim CEO of Harmless Harvest, Inc. He is also a Director and President of Danone Manifesto Ventures, Inc.
From 2011 to 2015, Mr. Marcel was Managing Director of Danone Nutricia India and then Managing Director of Danone India in Mumbai,
where he oversaw the integration of a leading company in the Indian baby food market as well as the reorganization of Danone&rsquo;s
activities in India. From 2007 to 2010, Mr. Marcel was the CFO of Danone Dairy Russia &amp; CIS in Moscow, where he oversaw the
acquisition of Unimilk, a large Russian dairy company, and from 2010 to 2011 he served as the CFO of Danone Unimilk and the head
of integration. Mr. Marcel joined Danone as a finance manager in 2002 in Paris, and in 2004 he became the CFO of Danone Aqua Indonesia
(Danone&rsquo;s water business in Indonesia) in Jakarta. Each of the above Danone entities are affiliated with Danone North America
Public Benefit Corporation. Mr. Marcel graduated from HEC and Paris Law School in 1994, and he started his career practicing law
in Paris and New York with a focus in mergers &amp; acquisitions and private equity. Mr. Marcel devotes as much time as necessary
to the business of the Company and currently holds no other directorships in any other reporting company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD RECOMMENDS THAT SHAREHOLDERS
VOTE &ldquo;FOR&rdquo; EACH OF THE NOMINEES NAMED ABOVE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROPOSAL TWO<BR>
RATIFICATION OF THE APPOINTMENT OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">At
a meeting held on April 13, 2018, Lifeway&rsquo;s Audit Committee unanimously recommended the reappointment of </FONT>Mayer Hoffman
McCann P. C. (&ldquo;MHM&rdquo;) <FONT STYLE="background-color: white">as our independent registered public accounting firm for
the fiscal year ending December&nbsp;31, 2018. While the Audit Committee is responsible for the appointment, compensation, retention,
termination, and oversight of the independent auditor, we are requesting, as a matter of good corporate governance, that at the
Annual Meeting shareholders ratify the selection of MHM as our independent registered public accounting firm. Our Audit Committee
first engaged MHM on September 12, 2015, and </FONT>MHM has been our independent registered public accounting firm since that date
for periods ending after December 31, 2014. A representative of MHM is expected to be present at the Annual Meeting and will have
an opportunity to make a statement, if desired, and respond to appropriate questions. The approval of the ratification of the appointment
of MHM as our independent auditors for the fiscal year ending December 31, 2018 requires the affirmative vote of a majority of
the Votes Cast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THE BOARD OF DIRECTORS RECOMMENDS THAT
SHAREHOLDERS VOTE &ldquo;FOR&rdquo; THE RATIFICATION OF THE APPOINTMENT OF MHM AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our shareholders elect the Board of Directors,
whose primary responsibility is to foster Lifeway&rsquo;s long-term health, growth, success, and financial condition, consistent
with its fiduciary duty to our shareholders. The Board serves as our ultimate decision-making body, except for those matters reserved
to or shared with the shareholders. The Board establishes broad corporate policies and selects and oversees the members of senior
management, who are charged by the Board with conducting Lifeway&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Voting for Directors; Director Resignation
Policy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each director in an uncontested election
must be elected by a majority of the Votes Cast at the Annual Meeting, or by a plurality of the Votes Cast at the Annual Meeting
in a contested election. If any nominee is not available for election at the time of the Annual Meeting (which is not anticipated),
the proxy holders named in the proxy, unless specifically instructed otherwise in the proxy, will vote for the election of such
other person as the existing Board may recommend, unless the Board decides to reduce the number of our directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with our Bylaws, under our Board&rsquo;s
policy, any director who fails to be elected must offer to tender his or her resignation to the Board. The Board nominates for
election or re-election as director, and fills director vacancies with, only those candidates who agree to tender their irrevocable
resignations upon (1) the failure to receive the required vote at the annual meeting at which they face election or re-election
and (2) Board acceptance of such resignation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an incumbent director fails to receive
the required vote for re-election, the Board and the Nominating Committee (or Audit Committee, if the Board has not established
a Nominating Committee) will act on an expedited basis to determine whether to accept the director&rsquo;s resignation and will
submit such recommendation for prompt consideration by the Board. The Board expects the director whose resignation is under consideration
to abstain from participating in any decision regarding that resignation. The Nominating (or Audit) Committee and the Board may
consider any factors they deem relevant in deciding whether to accept a director&rsquo;s resignation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Director Independence</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At least annually and in connection with
any individuals being nominated to serve on the Board, the Board reviews the independence of each director or nominee and affirmatively
determines whether each director or nominee qualifies as independent. The Board believes that shareholder interests are best served
by having a number of objective, independent representatives on the Board. A majority of the current Board, consisting of Mr. Bernardi,
Mr. Lee, Mr. Marcel, Mr. Scher, and Mr. Sikar, are &ldquo;independent directors&rdquo; as defined in the listing standards of Nasdaq
and none of them have relationships to Lifeway that are material to that director&rsquo;s ability to be independent from management
in connection with the duties of a board member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee is composed solely
of independent directors. In addition, the Board and the Audit Committee have complete and open access to any member of management
and the authority to retain independent legal, financial, and other advisors as they deem appropriate without consulting or obtaining
the approval of any member of management. The Board and Audit Committee also hold regularly scheduled executive sessions of only
independent directors to promote discussion among the independent directors and assure independent oversight of management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board Leadership</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board believes that shareholders are
best served if the Board retains flexibility to decide what leadership structure works best for Lifeway under its current facts
and in its current circumstances. Since 2002, the positions of Chairperson of the Board and Chief Executive at Lifeway have been
held by different individuals. Currently, Ludmila Smolyansky serves as Chairperson of the Board and Julie Smolyansky as Chief Executive
Officer. The Chief Executive Officer and the Chairperson of the Board have an excellent working relationship and offer Lifeway
a complementary array of skills, knowledge, and abilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Board policy, the chairperson
of the Audit Committee (currently Mr. Lee) also serves as the Board&rsquo;s Lead Independent Director. The Lead Independent Director
presides over meetings of independent directors. We believe that our leadership structure, with a separate Chief Executive Officer,
Chairperson of the Board, and Lead Independent Director, is optimal for us at this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board Role in Risk Oversight</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors recognizes that
although management is responsible for identifying and managing day-to-day risk, the Board and each of its directors play a critical
role in the oversight of risk. The Board implements its risk oversight responsibilities by having management provide periodic briefing
and informational sessions on the significant risks that Lifeway faces and how we are seeking to control risk if and when appropriate.
In some cases, a Board committee is responsible for oversight of specific risk topics. For example, the Audit Committee has oversight
responsibility of our internal audit function and risks associated with financial accounting and audits, internal control over
financial reporting, and major financial risk exposures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee also has primary responsibility
for overseeing risks related to data protection and cybersecurity, although the Board also exercises oversight over these risks.
This oversight includes reports to the Audit Committee and/or the Board on data protection and cybersecurity matters from senior
members of our information technology department, legal department, and internal audit function. The topics covered by these reports
include risk management strategies, data protection, ongoing risk mitigation activities, cybersecurity strategy, and governance
structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed in detail below, the Board
also has oversight responsibility of risks relating to Lifeway&rsquo;s compensation policies and practices. At each regular meeting,
or more frequently as needed, the Board considers reports from management and its committees that provide detail on risk management
issues and management&rsquo;s response. Beyond formal meetings, the Board has regular access to senior executives. Lifeway believes
that its leadership structure promotes effective Board oversight of risk management because management provides the Board, directly
and through the Audit Committee, the information necessary to appropriately monitor, evaluate, and assess our overall risk management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board Role in Compensation Oversight</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Led by the Audit Committee and the Board&rsquo;s
independent directors, the Board discharges its responsibilities related to compensation of Lifeway&rsquo;s executive officers
and administers our incentive and equity compensation plans. The Board also evaluates non-employee director compensation. In addition,
the Board is responsible for conducting a periodic risk evaluation of Lifeway&rsquo;s compensation practices, policies and programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2017, the Board engaged Willis Towers
Watson (&ldquo;Towers Watson&rdquo;) as its independent compensation consultant to advise it on executive and director compensation
matters. Towers Watson reports directly to the Board, and the Board has the sole power to terminate or replace Towers Watson at
any time. Towers Watson also has the opportunity to meet with the Board during its regular meetings, in executive session (where
no members of management are present), and with the independent members of the Board outside of the Board&rsquo;s regular meetings.
As part of its engagement in 2017, the Board directed Towers Watson to work with our General Counsel, our Human Resources department,
and other members of management to obtain information necessary for Towers Watson to evaluate management&rsquo;s recommendations
to the Board. Towers Watson evaluated our peer group composition, evaluated compensation levels at those peer group companies,
and assessed management&rsquo;s proposed base and incentive (cash and equity) compensation for Lifeway executives and senior management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2017, Towers Watson did not perform
any other services for Lifeway. The Board believes that there is no conflict of interest based on any prior relationship with Towers
Watson. In reaching this conclusion, the Board considered the factors set forth in the SEC and Nasdaq rules regarding compensation
advisor independence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board Role in Director Nominations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Led by the Audit Committee and the Board&rsquo;s
independent directors, the Board selects and evaluates qualified candidates for election or appointment to the Board, including
by identifying individuals qualified to become Board members and members of Board committees; nominates director nominees for the
next annual meeting of shareholders or for appointment to vacancies on the Board; and identifies individuals to serve as our executive
officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no specific minimum qualifications
that the Board believes that a director nominee must meet. However, the Board believes that director candidates should, among other
things, possess high degrees of integrity and honesty; have literacy in financial and business matters; have no material affiliations
with our direct competitors, suppliers, or vendors; and preferably have experience in our business and other relevant business
fields (for example, finance, accounting, law and banking). As a matter of policy, the Board considers diversity together with
other factors considered when evaluating candidates, but does not have a specific diversity requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board meets in advance of each of Lifeway&rsquo;s
annual meetings of shareholders to identify and evaluate the skills and characteristics of each potential nominee for election
as one of our directors. The Board reviews the candidates in accordance with the skills and qualifications set forth in its Corporate
Governance Guidelines and by Nasdaq rules. The Board evaluates all director candidates in the same manner, regardless of whether
a shareholder or some other source recommends them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Board Role in Management Succession
Planning</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">One of our Board&rsquo;s principal duties
is to review management succession planning. The Board reviews its management succession plans annually and plans for the development,
retention, and replacement of executive officers, including the Chief Executive Officer. Additionally, the Board oversees the risks
and exposures associated with management succession planning. Our Board believes that the directors and Lifeway&rsquo;s executive
officers should collaborate on succession planning and that the entire Board should be involved in the critical aspects of the
management succession planning process, including establishing selection criteria that reflect our business strategies, identifying
and developing internal candidates to ensure the continuity of our culture, and making key management succession decisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management succession is discussed by the
Board in regular meetings and in executive sessions of the Board as appropriate. Directors can become familiar with potential successors
for key management positions through various means, including regular organization and talent reviews, presentations to the Board,
and informal meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board Meetings and Attendance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board typically meets at least quarterly
and holds special meetings when necessary. During the 2018 fiscal year, the Board intends to hold at least six regularly scheduled
meetings and the independent directors serving on the Board intend to meet in executive session (i.e., without the presence of
any non-independent directors or management) immediately following at least two regularly scheduled Board meetings. During the
fiscal year ended December 31, 2017 (the &ldquo;Last Fiscal Year&rdquo;), the Board held five (5) meetings. Except for Renzo Bernardi,
who attended three of five meetings, all directors standing for re-election who served on the Board during the Last Fiscal Year
attended at least 75% of the total number of meetings of the Board and of the committees of the Board on which they served in the
Last Fiscal Year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to our Corporate Governance Guidelines,
the Board expects attendance by Directors at Lifeway&rsquo;s annual meetings. Each of the directors standing for re-election who
served on the Board during the Last Fiscal Year attended the 2017 Annual Meeting of Shareholders and each of the nominees currently
intends to attend this Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Communication with the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway&rsquo;s annual meeting of shareholders
provides an opportunity each year for shareholders to ask questions of, or otherwise communicate directly with, members of the
Board on appropriate matters. Shareholders who wish to contact the Board, any committee of the Board, or any individual director
or group of directors may do so by sending such written communications to Lifeway&rsquo;s Secretary or Assistant Secretary, c/o
Legal Department, Lifeway Foods, 6101 West Gross Point Road, Niles, Illinois 60714. The Secretary or Assistant Secretary will collect
and organize any copies of written communications that we receive and provide them to the Board or the relevant director unless
the Secretary or Assistant Secretary&rsquo;s reasonably determines that they are inappropriate for submission to the intended recipient(s).
Examples of shareholder communications that would be considered inappropriate for submission to the Board include, without limitation,
customer complaints, solicitations, communications that do not relate directly or indirectly to Lifeway&rsquo;s business, or communications
that relate to improper or irrelevant topics. The Secretary or Assistant Secretary or their designees may analyze and prepare a
response to the information contained in communications received and may deliver a copy of the communication to other Lifeway employees
or agents who are responsible for analyzing or responding to complaints or requests. Communications concerning possible director
nominees submitted by any of our shareholders will be forwarded to the independent directors of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Controlled Company Exemption</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because Ludmila Smolyansky, Julie Smolyansky,
and Edward Smolyansky, acting as a group, (the &ldquo;Smolyansky family&rdquo;) beneficially own a majority of Lifeway&rsquo;s
outstanding Common Stock, we qualify as a &ldquo;controlled company&rdquo; pursuant to Nasdaq Listing Rule 5615. As a controlled
company, we are exempt from the requirements to have separate, independent compensation and nominating committees; a majority of
independent directors on our Board; or independent directors comprising a majority of the Board select nominees for director or
determine the compensation of its officers. We have chosen to take advantage of the controlled company exemptions described above.
However, we continue to maintain a majority of independent directors on the Board and those independent directors continue to select
director nominees and determine officer compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that having the Smolyansky family
as a significant part of a long-term-focused, committed, and engaged stockholder base provides us with an important strategic advantage,
particularly in a business with a mature, well-recognized brand. We desire to remain independent and family-controlled, and we
believe the Smolyansky family shares these interests. As a result of our use of the controlled company exemption, our corporate
governance practices differ from those of non-controlled companies, which are subject to all of the Nasdaq corporate governance
requirements. In the event we cease to be a controlled company, we will be required to comply with all of the corporate governance
standards under Nasdaq&rsquo;s rules, subject to applicable transition periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Committees of the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because Lifeway avails itself of the controlled
company exemption, it maintains one standing committee: the Audit Committee. All members of the Audit Committee are independent
directors, as defined in the applicable rules for companies traded on Nasdaq. The Board of Directors has adopted a written charter
for the Audit Committee. The Board and the Audit Committee most recently reviewed the charter in August 2017 and do so at least
annually. Although the Board does not currently maintain a Compensation Committee or Nominating Committee, it and the Audit Committee
consider our Corporate Governance Guidelines and the guidelines in the former charters for those committees when discharging compensation
and nominating oversight duties. Current copies of Lifeway&rsquo;s Corporate Governance Guidelines, committee charters, and other
key corporate governance documents are available on our website at www.lifewayfoods.com under Investor Relations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Audit Committee</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee consisted of Messrs.
Sikar, Lee, and Scher in the Last Fiscal Year. Mr. Lee was the Chairperson of the Audit Committee. The Audit Committee held six
(6) meetings in the Last Fiscal Year. The Audit Committee oversees the adequacy and effectiveness of our internal controls and
meets with Lifeway&rsquo;s internal and independent auditors to review these internal controls and to discuss other financial reporting
matters. The Audit Committee is also responsible for the selection, appointment, compensation, and oversight of the auditors. The
Audit Committee reviews the financial reporting and accounting principles and standards and the audited financial statements to
be included in the annual report. It also reviews the quarterly financial results and related disclosures. Additionally, the Audit
Committee is responsible for the review and oversight of all related party transactions and other potential conflict of interest
situations between and among Lifeway and its officers, directors, employees, and principal shareholders. The Audit Committee relies
on the expertise and knowledge of management, our internal auditor, and our independent auditor in carrying out its oversight responsibilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has determined&nbsp;that each
member of the Audit Committee (1) is &ldquo;independent&rdquo; as defined by applicable SEC rules and the listing standards of
Nasdaq, (2) has not participated in the preparation of our financial statements or those of any of our current subsidiaries at
any time during the past three years, and (3) is able to read and understand fundamental financial statements, including a balance
sheet, income statement, and cash flow statement. In addition, the Board has determined that Mr. Lee is financially literate and
financially sophisticated, as those terms are defined under the rules of Nasdaq, and is an &ldquo;audit committee financial expert,&rdquo;
as defined by applicable SEC rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Committees Dissolved During the Last Fiscal Year</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the Last Fiscal Year prior to its
dissolution in November 2017 when Lifeway availed itself of the &ldquo;controlled company&rdquo; exemption in Nasdaq Listing Rule
5615, the Board maintained a Compensation Committee. The Compensation Committee consisted of Messrs. Scher and Lee. Mr. Scher was
the Chairperson of the Compensation Committee. The Compensation Committee held one (1) meeting during the Last Fiscal Year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Similarly, during the Last Fiscal Year
prior to its dissolution in November 2017 when Lifeway availed itself of the &ldquo;controlled company&rdquo; exemption in Nasdaq
Listing Rule 5615, the Board also maintained a Nominating Committee. The Nominating Committee consisted of Messrs. Lee and Scher.
Mr. Scher was the Chairperson of the Nominating Committee. The Nominating Committee held one (1) meeting during the Last Fiscal
Year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Annual Board and Committee Evaluations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each year, as required by our Corporate
Governance Guidelines, our Board and its Committees conduct evaluations to assess their effectiveness and adherence to the Lifeway&rsquo;s
Code of Ethics, Corporate Governance Guidelines, policies adopted by the Board, and committee charters, and to identify opportunities
to improve Board and committee performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Board&nbsp;evaluation</I>&nbsp;&ndash;
The Directors conduct an annual evaluation of the performance of the Board and each of its members. The aggregate results are reported
to the Board. The report includes an assessment of the Board&rsquo;s compliance with our Code of Ethics, corporate governance guidelines,
and policies adopted by the Board, and identification of areas in which the Board could improve its performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Committee&nbsp;evaluations</I>&nbsp;&ndash;
Each Committee conducts an annual performance evaluation and reports the results to the Board. Each committee&rsquo;s report includes
an assessment of the committee&rsquo;s compliance with our Code of Ethics, corporate governance guidelines, policies adopted by
the Board, the committee&rsquo;s charter, and identification of areas in which the committee could improve its performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Director Nominations by Shareholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with the Board&rsquo;s Corporate
Governance Guidelines, the Board will consider any candidates recommended by shareholders on the same basis that it considers recommendations
from other sources. The recommendation must at a minimum include evidence of the shareholder&rsquo;s ownership of Lifeway stock,
along with the candidate&rsquo;s name and qualifications for service as a Board member, and a document signed by the candidate
indicating the candidate&rsquo;s willingness to serve, if elected. In considering a candidate submitted by shareholders, the Board
will take into consideration the needs of the Board and the qualifications of the candidate. Nevertheless, just as with recommendations
from other sources, the Board may choose not to consider an unsolicited recommendation if no vacancy exists on the Board and/or
the Board does not perceive a need to increase number of directors on the Board. Shareholders should submit any recommendations
of director candidates for Lifeway&rsquo;s 2019 Annual Meeting of Shareholders to the Secretary or Assistant Secretary, c/o Legal
Department, Lifeway Foods, 6101 West Gross Point Road, Niles, Illinois 60714, (847) 967-1010 in accordance with the procedures
set forth above under the heading &ldquo;Deadline for Receipt of Shareholder Proposals to be Presented at Our Next Annual Meeting.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Website Access to Corporate Governance Documents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have adopted Corporate Governance Guidelines
and a Code of Ethics applicable to all members of the Board, executive officers, and employees, including our principal executive
officer and principal financial officer. The Corporate Governance Guidelines, the Code of Ethics, and other corporate governance
documents are available on our website at&nbsp;www.lifewayfoods.com. Information contained on the website is not incorporated by
reference in, or considered part of, this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Certain Relationships and Related Party Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have determined that there were no related
party transactions in excess of $120,000 since January 1, 2016, or currently proposed, involving Lifeway except for the consulting
arrangement with Ludmila Smolyansky, our Chairperson of the Board, as further discussed in footnote 1 to the Directors&rsquo; Compensation
table and as set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 14, 2016, we entered into an endorsement
agreement (the &ldquo;Endorsement Agreement&rdquo;) with Mrs. Smolyansky that was effective January 1, 2016. Under the terms and
conditions of the Endorsement Agreement, Mrs. Smolyansky grants an unlimited, perpetual, non-exclusive, worldwide and, except as
set forth therein, royalty free, right to use, reuse, publish, reproduce, perform, copy, create derivative works, exhibit, broadcast
and display Mrs. Smolyansky&rsquo;s name, image and likeness in Marketing Materials (as defined in the Agreement). As consideration
for such license, we agree to pay Mrs. Smolyansky a royalty equal to $0.02 for each product or item sold by Lifeway during each
calendar month bearing Mrs. Smolyansky&rsquo;s first name, last name, or other identifying personal characteristics; provided however
that such royalty will not exceed $50,000 in any month and such royalty payments will cease upon the death of Mrs. Smolyansky.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 18, 2016, Lifeway entered into
a consulting agreement (the &ldquo;Consulting Agreement&rdquo;) with Mrs. Smolyansky that was effective January 1, 2016. Under
the terms and conditions of the Agreement, Mrs. Smolyansky will continue to provide consulting services with respect to our business
strategy, international expansion, and product management and expansion for which we will pay Mrs. Smolyansky an aggregate of $1,000,000
annually and prorated amounts for periods shorter than a year. The Consulting Agreement is terminable by either party on ten days&rsquo;
prior written notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Insider Trading Policy and Rule 10b5-1
Sales Plans</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with our Corporate Governance
Guidelines, we have an insider trading policy that prohibits our officers, directors, and certain other employees and persons from
engaging in, among other things, short sales, hedging of stock ownership positions, and transactions involving derivative securities
relating to Lifeway&rsquo;s common stock without prior approval of Lifeway&rsquo;s designated compliance officer and the Board
of Directors. Our insider trading policy permits our officers, directors, and employees to enter into trading plans complying with
Rule 10b5-1 under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Executive and Director Stock Ownership
and Holding Policy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2018, our Board adopted a stock ownership
and holding policy to better align the interests of our executive officers and independent directors with the interests of stockholders
and further promote our commitment to sound corporate governance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the policy, our executive officers
are required to own Lifeway Common Stock valued at 100% of their annual base salary. The individual minimum level for each executive
officer is initially calculated using the executive officer&rsquo;s base salary as of the date the person is first appointed as
an executive officer. This minimum level is then recalculated each January 1st. Unless an executive officer has satisfied his or
her applicable minimum ownership level, the executive officer is required to retain an amount equal to 50% of the net shares received
as the result of the exercise, vesting, or payment of any equity awards granted to him or her. Thereafter, executive officers are
required to (i) retain 25% of all such net shares, and (ii) continuously own sufficient numbers of shares to satisfy the minimum
ownership requirement once attained, for so long as they remain executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The policy also requires each independent
director to own Lifeway Common Stock valued at 100% of the annual retainer payable to such director. The policy provides that if
Lifeway awards shares to independent directors, those directors must retain 50% of all net shares (post tax) that vest until the
director meets the minimum share ownership requirement and 25% of all such net shares thereafter. This individual minimum level
is then recalculated each year when an independent director is elected or re-elected to the Board. Our policy requires independent
directors to whom we award shares to continuously own sufficient numbers of those shares to satisfy the requirements once attained
for so long as they remain members of our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares that count toward satisfaction of
the stock ownership requirements for executive officers and directors include the following: (i) vested shares held outright or
beneficially owned by the executive officer or director, regardless of how acquired; (ii) vested shares held by the spouse or dependent
children of the executive officer or director; (iii) vested shares held in trust for the economic benefit of the executive officer
or director, or the spouse or dependent children of the executive officer or director; (v) vested shares held in a 401(k), IRA,
or other retirement plan. The following do not count towards satisfaction of the stock ownership guidelines: (i) unvested shares
of any type; (ii) shares subject to pledge as collateral for a loan or in a margin account; (iii) unexercised stock options (whether
vested or unvested); and (iv) vested incentive performance awards that are settled in cash rather than equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms. Smolyansky and Mr. Smolyansky have
satisfied the ownership requirements, and Mr. Waldron, Ms. Reilly, and Mr. Hass are progressing toward attaining their applicable
executive officer ownership requirements. Mr. Bernardi has satisfied the ownership requirements. Mr. Sikar, Mr. Lee, and Mr. Scher
are progressing toward attaining their applicable independent director ownership requirements. Given Danone North America PBC&rsquo;s
(&ldquo;Danone&rdquo;) ownership of over 21% of Lifeway&rsquo;s common stock and Mr. Marcel&rsquo;s status as Danone&rsquo;s designated
director, the Board has determined that he is exempt from these requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exceptions to these share ownership and
holding requirements may be made at the discretion of the Board if compliance would create severe hardship or prevent an executive
officer or director from complying with a court order, such as part of a divorce settlement. The Board expects these instances
will be rare. If an exception is granted in whole or in part, the Board will, in consultation with the affected executive officer
or director, develop an alternative stock ownership guideline for that individual that reflects both the intention of the policy
and that individual&rsquo;s particular circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The stock ownership guidelines are administered,
interpreted, and construed by the Board. In administering the stock ownership and holding policy, the Board will annually review
the extent to which each of our executive officers and directors has complied with the stock ownership policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ownership levels of our named executive
officers and non-employee directors as of the Record Date are set forth in the table entitled &ldquo;Ownership of Common Stock
by Certain Beneficial Owners and Management&rdquo; below. The stock ownership and holding policy described above prescribes the
amount and length of time executives or directors have to hold their stock after exercise or vesting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OWNERSHIP OF COMMON STOCK BY CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the Record Date, Lifeway&rsquo;s
directors and &ldquo;Named Executive Officers&rdquo; (&ldquo;NEOs&rdquo;) beneficially own, directly or indirectly, in the aggregate,
approximately 50.7% of its outstanding Common Stock. These shareholders have significant influence over our business affairs, with
the ability to control matters requiring approval by our shareholders, including the two proposals set forth in this Proxy Statement
and other matters such as approvals of mergers or other business combinations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth, as of the
Record Date, certain information with respect to the beneficial ownership of the Common Stock for (i) each person known by Lifeway
to beneficially own more than 5% of the outstanding shares of our Common Stock, (ii) each of our directors, (iii) each of our NEOs,
and (iv) all of our directors and executive officers as a group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>COMMON STOCK</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1pt"></TD><TD COLSPAN="4" STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Shares Beneficially Owned (b)&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">Name and Address (a)</TD>
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1pt solid">Number</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; border-bottom: Black 1pt solid">Percent</TD><TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 68%; text-align: left">Ludmila Smolyansky</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; text-align: right">5,251,309</TD><TD STYLE="width: 3%; text-align: center">(c)</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; text-align: right">33.1%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Julie Smolyansky</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,768,864</TD><TD STYLE="text-align: center">(d)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.1%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Edward Smolyansky</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,508,504</TD><TD STYLE="text-align: center">(e)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.5%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">John Waldron</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,208</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Renzo Bernardi</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,900</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Pol Sikar</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,000</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Paul Lee</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Jason Scher</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Laurent Marcel</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Danone North America PBC <BR>100 Hillside Avenue <BR>White Plains, NY 10603-2861</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,454,756</TD><TD STYLE="text-align: center">(f)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21.8%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">All directors and executive officers as a group <BR>(11 persons)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,056,774</TD><TD STYLE="text-align: center">(g)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50.7%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">____________</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 0pt">*</TD><TD>Less than 1%</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Unless otherwise indicated, the business address of each person or entity named in the table is
c/o Lifeway Foods, Inc., 6431 Oakton St., Morton Grove, IL 60053.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">Applicable percentage of ownership is based on 15,877,851 shares of Common Stock outstanding as
of the Record Date. Beneficial ownership is determined in accordance with SEC rules and includes voting and investment power with
respect to shares. Shares of Common Stock subject to options, warrants, or other convertible securities exercisable within 60 days
after the Record Date are deemed outstanding for computing the percentage ownership of the person holding such options, warrants,
or other convertible securities, but are not deemed outstanding for computing the percentage of any other person. Except as otherwise
noted, the named beneficial owner has the sole voting and investment power with respect to the shares of Common Stock shown.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">Includes (i) 5,223,966 shares held by the Ludmila Smolyansky Trust 2/1/05, of which Mrs. Smolyansky
is the trustee and (ii) 27,343 shares held by The Smolyansky Family Foundation, of which Mrs. Smolyansky is the trustee. Includes
an aggregate of 1,759,000 shares subject to pledge in accordance with the terms and conditions of a full recourse loan agreement
with a lender.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">Includes (i) 22,216 shares held by Ms. Smolyansky on behalf of minor children, (ii) 4,636 shares
held by Ms. Smolyansky&rsquo;s spouse and (iii) 500,000 shares held by Smolyansky Family Holdings, LLC (the &ldquo;Smolyansky LLC&rdquo;)
of which Ms. Smolyansky beneficially owns 50%. Ms. Smolyansky shares the power to vote and dispose of the shares held by the Smolyansky
LLC with Mr. Smolyansky. Ms. Smolyansky disclaims beneficial ownership of the shares held by the Smolyansky LLC except to the extent
of any pecuniary interest therein.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify">Includes 500,000 shares held by the Smolyansky LLC of which Mr. Smolyansky beneficially owns 50%.
Mr. Smolyansky shares the power to vote and dispose of the shares held by the Smolyansky LLC with Ms. Smolyansky. Mr. Smolyansky
disclaims beneficial ownership of the shares held by the Smolyansky LLC except to the extent of any pecuniary interest therein.
Includes an aggregate of 116,081 shares subject to pledge in accordance with the terms and conditions of a brokerage firm&rsquo;s
customary margin account requirements.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify">Based on information known to Lifeway.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify">Includes (i) 5,223,966 shares held by the Ludmila Smolyansky Trust 2/1/05, of which Ludmila Smolyansky
is the trustee, (ii) 27,343 shares held by The Smolyansky Family Foundation, of which Ludmila Smolyansky is the trustee, (iii)
22,216 shares held by Julie Smolyansky on behalf of minor children, (iv) 4,636 shares held by Julie Smolyansky&rsquo;s spouse and
(iii) 500,000 shares held by the Smolyansky LLC of which Julie Smolyansky and Edward Smolyansky each beneficially owns 50%.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXECUTIVE OFFICER AND DIRECTOR COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Executive Officers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway&rsquo;s executive officers are
Ms. Julie Smolyansky, Chief Executive Officer, President, and a Director; Mr. Edward Smolyansky, Chief Operating Officer, Treasurer,
and Secretary, and a Director; Mr. John Waldron, Chief Financial Officer and Chief Accounting Officer; Mr. Douglas Hass, General
Counsel and Assistant Corporate Secretary; and Ms. Jennifer Reilly, Senior Executive Vice President of Sales. Biographical information
for Ms. Smolyansky and Mr. Smolyansky is included above in Proposal One.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">JOHN P. WALDRON, 53, is the Chief Financial
and Accounting Officer of the Company. He joined Lifeway as Vice President of Finance in July 2015, became Chief Financial Officer
on January 1, 2016, and became Chief Accounting Officer on August 8, 2016. Prior to his employment at the Company, Mr. Waldron
was a financial consultant at Tatum during 2015, counseling a large public company on effective controllership capabilities. Previously,
Mr. Waldron was Vice President, Controller and Chief Accounting Officer at Campbell Soup Company from 2011 to 2013 and Vice President,
Controller and Chief Accounting Officer of Navistar from 2006 to 2010. Prior to 2006, Mr. Waldron held various financial leadership
positions with private and public companies including RR Donnelley, the Follett Corporation, Dominick&rsquo;s Supermarkets and
Terrific Promotions. Mr. Waldron began his career at Arthur Andersen and he is a graduate of Loyola University of Chicago.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DOUGLAS A. HASS, 42, is the General Counsel
and Assistant Corporate Secretary of the Company. He has more than twenty years of legal, management, and operations experience,
centered on technology-intensive businesses. He joined Lifeway as Legal Counsel in March 2016 from international law firm DLA Piper
LLP (US) and became General Counsel and Assistant Corporate Secretary on November 7, 2016. From 2009 through 2016, in private practice,
Mr. Hass advised and represented a wide range of federal and state government and public and privately held clients on a variety
of labor and employment, corporate, and technology/new media issues, as well as associated corporate law and litigation matters.
From 1998 until 2006, Mr. Hass was Chief Operations Officer at ImageStream, a multinational telecommunications and Internet networking
equipment manufacturer. Prior to 1998, Mr. Hass was Vice President and Partner at Skye/net, a major Midwest-based Internet service
provider. He holds a Juris Doctor from Indiana University Maurer School of Law in Bloomington, Indiana.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">JENNIFER REILLY, 44, is the Senior Executive
Vice President of Sales of the Company. Prior to joining Lifeway, Ms. Reilly led the National Accounts and Sales Planning Teams
for Quaker Foods, a division of PepsiCo that generated over $3 billion in sales annually. Prior to this position, she was the Vice
President of PepsiCo Warehouse Sales&rsquo; regional grocery business in the U.S. In this role, she led the field sales and retail
execution teams managing Gatorade, Tropicana, Quaker, M&uuml;ller, Naked and Emerging Brands across six regions within the U.S.
In addition, Ms. Reilly held several headquarters &amp; field sales roles during her 11-year tenure with PepsiCo. Prior to PepsiCo,
Ms. Reilly spent nine years with Colgate-Palmolive holding key customer management roles including Target, Dollar General, Associated
Wholesale Grocers and Valu Merchandisers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Named Executive Officers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain
information concerning compensation received by Lifeway&rsquo;s NEOs, consisting of our Chief Executive Officer and the two other
most highly paid executive officers for services rendered in all capacities during the Last Two Fiscal Years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="16" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Summary Compensation Table</B></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Name and Principal Position(s)</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Year</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Salary ($)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Bonus <BR>($)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Stock<BR> Awards<BR> ($)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Option Awards <BR>($)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Nonequity<BR>
 incentive plan<BR>
 compensation ($)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">All Other<BR>
 Compensation<BR>
 ($)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid">Total ($)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 23%; text-align: left">Julie Smolyansky</TD>
    <TD STYLE="width: 7%; text-align: center">2017</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">1,000,000</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">&ndash;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">575,000(1)</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">&ndash;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">742,438(2)</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">49,539(3)</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 8%; text-align: center">2,366,977</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Chief Executive officer and President</TD>
    <TD STYLE="text-align: center">2016</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1,000,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">860,000(4)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">41,867(5)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1,901,867</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Edward Smolyansky</TD>
    <TD STYLE="text-align: center">2017</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1,000,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">575,000(6)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">742,438(7)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">49,504(8)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2,366,942</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Chief Operating Officer, Secretary, and Treasurer</TD>
    <TD STYLE="text-align: center">2016</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1,000,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">860,000(9)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">43,946(10)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">1,903,946</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">John Waldron</TD>
    <TD STYLE="text-align: center">2017</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">400,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">40,000(11)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">110,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12,933(12)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">562,933</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Vice President of Finance and Chief Financial and Accounting Officer (13)</TD>
    <TD STYLE="text-align: center">2016</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">325,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">75,000</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">26,340(14)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&ndash;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10,600(15)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">436,940</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 36px"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">An award of time-based Performance Shares pursuant to the
    Omnibus Plan. The amounts reported in this column represent the value consistent with the estimate of aggregate
    compensation cost to be recognized over the service period for the stock awards granted for fiscal 2017. The maximum value of
    the restricted awards for fiscal 2017 assuming achievement of all of performance measures was $1,725,000. As discussed below
    in the section &ldquo;Consent by Danone to Common Stock Issuances to Lifeway&rsquo;s CEO and COO pursuant to the Omnibus
    Plan,&rdquo; we must obtain Danone&rsquo;s consent before issuing these Performance Shares when they vest (if at
    all).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">As discussed below in the section &ldquo;Consent by Danone to Common Stock Issuances to Lifeway&rsquo;s CEO and COO pursuant to the Omnibus Plan,&rdquo; includes $287,500 of vested stock awards (Performance Shares) earned for fiscal year 2017 that were ultimately settled in cash as nonequity incentive plan compensation because Danone declined to consent to issuances of performance-based, long-term incentive stock awards to Ms. Smolyansky.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Includes (a) $10,800 representing Lifeway&rsquo;s matching contributions to the 401(k) plan on behalf of Ms. Smolyansky; (b) a car allowance of $28,277; and (c) the reimbursement of personal legal fees and expenses associated with her employment of $9,033. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">As discussed below in the section &ldquo;Consent by Danone to Common Stock Issuances to Lifeway&rsquo;s CEO and COO pursuant to the Omnibus Plan,&rdquo; includes $100,000 of vested stock awards (Performance Shares) earned for fiscal year 2016 that were ultimately settled in cash as nonequity incentive plan compensation because Danone declined to consent to issuances of performance-based, long-term incentive stock awards to Ms. Smolyansky.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Includes (a) $10,600 representing Lifeway&rsquo;s matching contributions to the 401(k) plan on behalf of Ms. Smolyansky and (b) $27,466 of payments related to personal usage of a Company-leased vehicle by Ms. Smolyansky.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">An award of time-based Performance Shares pursuant to the Omnibus Plan. The amounts
    reported in this column represent the value consistent with the estimate of aggregate compensation cost to be recognized over
    the service period for the stock awards granted for fiscal 2017. The maximum value of the restricted awards for fiscal 2017
    assuming achievement of all of performance measures was $1,725,000. As discussed below in the section &ldquo;Consent by
    Danone to Common Stock Issuances to Lifeway&rsquo;s CEO and COO pursuant to the Omnibus Plan,&rdquo; we must obtain
    Danone&rsquo;s consent before issuing these Performance Shares when they vest (if at all).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">As discussed below in the section &ldquo;Consent by Danone to Common Stock Issuances to Lifeway&rsquo;s CEO and COO pursuant to the Omnibus Plan,&rdquo; includes $287,500 of vested stock awards (Performance Shares) earned for fiscal year 2017 that were ultimately settled in cash as nonequity incentive plan compensation because Danone declined to consent to issuances of performance-based, long-term incentive stock awards to Mr. Smolyansky.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 36px">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Includes (a) $10,800 representing Lifeway&rsquo;s matching contributions to the 401(k) plan on behalf of Mr. Smolyansky; (b) a car allowance of $26,886; and (c) the reimbursement of personal legal fees and expenses associated with his employment of $8,116.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">As discussed below in the section &ldquo;Consent by Danone to Common Stock Issuances to Lifeway&rsquo;s CEO and COO pursuant to the Omnibus Plan,&rdquo; includes $100,000 of vested stock awards (Performance Shares) earned for fiscal year 2016 that were ultimately settled in cash as nonequity incentive plan compensation because Danone declined to consent to issuances of performance-based, long-term incentive stock awards to Mr. Smolyansky.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(10)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Consists of (a) $10,600 representing Lifeway&rsquo;s matching contributions to the 401(k) plan on behalf of Mr. Smolyansky, (b) $26,637 of payments related to personal usage of a Company-leased vehicle by Mr. Smolyansky and (c) $6,709 treated as compensation to Mr. Smolyansky under a non-accountable expense plan.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(11)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">An award of time-based Performance Shares pursuant to the Omnibus Plan.&nbsp;&nbsp;The amounts reported in this column represent the value consistent with the estimate of aggregate compensation cost to be recognized over the service period for the stock awards granted for fiscal 2017. The maximum value of the restricted awards for fiscal 2017 assuming achievement of all of performance measures was $750,000.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(12)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Includes (a) $10,800 representing Lifeway&rsquo;s matching contributions to the 401(k) plan on behalf of Mr. Waldron and (b) an Internet/telecommunications services allowance of $1,923.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(13)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Mr. Waldron was appointed as our Chief Financial Officer effective January 1, 2016, and as our Chief Accounting Officer effective August 8, 2016.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(14)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The amounts reported in this column represent the grant date fair value of the option awards granted in fiscal 2016 calculated in accordance with FASB ASC Topic 718. The assumptions we used in calculating these amounts are included in Note 12 to the Consolidated Financial Statements in our 2016 Form 10-K.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">(15)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Consists of $10,600 representing the Company&rsquo;s matching contributions to the 401(k) plan on behalf of Mr. Waldron.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2017, the Board&rsquo;s Compensation
Committee approved Performance Measures for each Performance Period in 2017 tied to three payout tiers: 85% of goal (threshold),
100% of goal (target), and 111-115% of goal (excellence). Had Lifeway achieved the third payout tier (that is 111-115% of the target
goals) for each of the 2017 Performance Periods, Ms. Smolyansky and Mr. Smolyansky each would have earned the maximum incentive
compensation of $3,450,000 ($1,725,000 in short-term, nonequity incentive compensation and $1,725,000 in long-term, equity-based
incentive compensation) and Mr. Waldron would have earned the maximum incentive compensation of $750,000 in long-term, equity-based
incentive compensation. Based on our 2017 financial performance:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Ms. Smolyansky and Mr. Smolyansky achieved the first tier of the quarterly net revenue measures
in the first two quarters of 2017 and did not achieve a payout tier in the third and fourth quarters of the 2017 Performance Periods.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Ms. Smolyansky and Mr. Smolyansky achieved the third payout tier of the first semi-annual adjusted
EBITDA measure and did not achieve a payout tier for the second semi-annual adjusted EBITDA measure of the 2017 Performance Periods.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Mr. Waldron achieved the first tier of the annual net revenue measure of the 2017 Performance Periods.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Mr. Waldron did not achieve a payout tier for the annual adjusted EBITDA measure for the 2017 Performance
Periods.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All long-term, equity-based incentive compensation
is subject to the vesting and continued employment requirements described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms. Smolyansky and Mr. Smolyansky were
not eligible for short-term, nonequity incentive compensation for personal performance goal achievement in 2017. The Compensation
Committee approved short-term nonequity incentive compensation for personal performance goal achievement by Mr. Waldron in the
2017 Performance Periods. The goals were a mixture of subjective and qualitative measures regarding the management of his department,
support of specific Company-wide objectives, and departmental milestones. If Mr. Waldron had achieved all of his personal performance
goals during the 2017 Performance Periods, he would have earned the maximum short-term nonequity incentive compensation of $200,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Incentive Plan Program </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our NEOs and other key employees designated
by the Board are eligible to receive nonequity awards and awards of Performance Units under Lifeway&rsquo;s 2015 Omnibus Incentive
Plan (the &ldquo;Omnibus Plan&rdquo;), the latter of which will result in grants of Performance Shares with time-based vesting
requirements if Lifeway exceeds specified financial performance criteria set by the Board. The amount and value of the awards depend
on our performance relative to the performance goals approved by the Board at the beginning of the Performance Period. The 2017
and 2018 Performance Unit cycles have one-year Performance Periods for all plan participants except the CEO and COO. The 2016,
2017, and 2018 Performance Unit cycles for the CEO and COO have both quarterly and semi-annual Performance Periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Performance Unit program, assuming
above-minimum threshold performance, time-based Performance Shares will be granted to the eligible participants, including NEOs,
pursuant to the Omnibus Plan and the terms and conditions of the applicable award agreements. For the reasons discussed below in
the section &ldquo;Consent by Danone to Common Stock Issuances to Lifeway&rsquo;s CEO and COO pursuant to the Omnibus Plan,&rdquo;
no Performance Shares were awarded to executive officers in 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the 2017 and 2018 performance periods,
Performance Share awards granted to eligible participants will vest, if at all, 1/3 one year after the grant is made and following
the completion of the Performance Period; 1/3 in the following year, more than one full year following the completion of the Performance
Period; and 1/3 in the third year, more than two full years following the completion of the Performance Period. An award (or part
thereof) only vests if the eligible participant remains employed by Lifeway on the vesting date. The Board believes that the post-performance
period vesting and continued employment features of Performance Share Awards provide important mechanisms that help to retain NEOs
and other key employees and to align their interests with long-term shareholder value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table outlines the Performance Periods and performance
measures and the Board&rsquo;s rationale for their selection:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 21%"><FONT STYLE="font-size: 10pt"><B>Performance Periods</B></FONT></TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 76%"><FONT STYLE="font-size: 10pt">2016 through 2018</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt"><B>Performance</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Measures</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Net revenue</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Adjusted EBITDA<SUP>(1)</SUP></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt"><B>Rationale</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board believes these measures are key drivers of our long-term
        success and shareholder value, and directly affected by the decisions of management.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Adjusted EBITDA measure helps ensure that leaders are accountable
        for driving profitable growth, and making appropriate tradeoffs between investments that increase operating expense and future
        growth in revenue.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&ldquo;Adjusted EBITDA&rdquo; is not defined under U.S. generally accepted accounting principles (&ldquo;GAAP&rdquo;) and is not a deemed alternative to measure performance under GAAP. EBITDA is defined as net income before income taxes, net interest expense, depreciation and amortization, impairment of long lived assets, stock-based compensation, and similar items.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The likelihood of our NEOs and other key
employees receiving nonequity and equity incentive awards in 2018 is dependent on our 2018 financial results, which in turn are
dependent on many other factors. As demonstrated by the incentive payouts for 2017, we seek to have target financial and personal
goals that maintain a consistent level of difficulty in achieving the full target bonus from year to year. Therefore, over time
we expect our NEOs and other key employees to achieve bonuses in some years and not achieve bonuses in other years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Consent by Danone to Common Stock Issuances
to Lifeway&rsquo;s CEO and COO pursuant to the Omnibus Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Stockholders&rsquo; Agreement
dated October 1, 1999, as amended, among Lifeway, members of the Smolyansky family, and Danone, Danone must give its consent to,
among other things, issuances of performance-based, long-term incentive stock awards to our CEO and COO pursuant to our Omnibus
Plan. Lifeway achieved certain Board-approved Performance Measures under our Omnibus Plan during 2016 Performance Periods for which
Ms. Smolyansky and Mr. Smolyansky earned long-term incentive stock awards, subject to vesting. Accordingly, in August 2016, we
tried to obtain Danone&rsquo;s consent to the issuance of 9,416 Performance Shares each to Ms. Smolyansky and Mr. Smolyansky, the
number of awarded Performance Shares that had vested. However, Danone declined to give consent. Therefore, the Board&rsquo;s Compensation
Committee later cancelled and extinguished this Performance Share award in exchange for cash payments to Ms. Smolyansky and Mr.
Smolyansky in the amount of $100,000 each, the value of the awards when they had vested. For this reason, no Performance Shares
were awarded to executive officers in 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Similarly, Lifeway achieved certain Board-approved
Performance Measures under our Omnibus Plan during 2017 Performance Periods for which Ms. Smolyansky and Mr. Smolyansky earned
long-term incentive stock awards, subject to vesting. Accordingly, in January 2018, we tried to obtain Danone&rsquo;s consent to
the issuance of 42,910 Performance Shares each to Ms. Smolyansky and Mr. Smolyansky, the number of Performance Shares that would
have vested in March 2018 under our Omnibus Plan. However, Danone declined to give consent. Therefore, the Board&rsquo;s Audit
Committee later cancelled and extinguished this Performance Share award in exchange for cash payments to Ms. Smolyansky and Mr.
Smolyansky in the amount of $287,500 each, the value of the vested portion of the Performance Share award on its vesting date.
The remainder of the Performance Share awards to Ms. Smolyansky and Mr. Smolyansky for 2017 Performance Periods is subject to the
vesting schedule previously approved by the Board&rsquo;s Compensation Committee in January 2017. The awards will vest, if at all,
in 2019 and 2020, and will require Danone&rsquo;s consent prior to issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Employment agreements, severance, and change-in-control
arrangements between Lifeway and Named Executive Officers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NEO Compensation Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway believes the interests of the Company
and its shareholders are best served by developing and maintaining compensation policies that are consistent and competitive with
peer group companies. Therefore, each year, the Board, in consultation with management, analyzes market data regarding base salary,
cash bonus awards, equity incentive awards, and other benefits paid to executive officers and independent directors by companies
the Board considers our primary peer group. The Board relies on management and external research to identify the individual companies
that make up this group. In identifying the peer group of surveyed companies, management uses the Economic Research Institute,
an industry- and region-specific compensation database, to assemble market data on publicly-traded companies having similar industrial
characteristics and revenues to ours. Management and the Board review the gathered data for each of the independent director, NEO,
and other key employee positions and adjust for the scope of employee&rsquo;s responsibilities at Lifeway as compared to equivalent
responsibilities of positions within companies included in the survey data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NEO Employment Agreements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Julie Smolyansky serves Lifeway pursuant
to an employment agreement dated as of September 12, 2002. Pursuant to the agreement, Ms. Smolyansky is entitled to an annual base
salary and an annual bonus subject to such incentive bonus targets and plans that Lifeway may adopt from time to time. In each
of 2016, 2017, and 2018, Ms. Smolyansky was entitled to receive an annual base salary of $1,000,000, an amount that the Board reviews
annually. She is also eligible for certain cash, equity, and other incentive awards based on the satisfaction of the Board&rsquo;s
pre-established performance goals. In 2017 and 2018, the Board has set bonus targets in compliance with its Omnibus Plan and applicable
IRS regulations governing performance-based compensation for which Ms. Smolyansky is eligible. In the event that (a) Ms. Smolyansky
is terminated other than for Cause (as defined therein) or (b) Ms. Smolyansky terminates her employment for Good Reason (as defined
in the agreement) or due to her death, then Ms. Smolyansky is entitled to a lump sum payment consisting of (y) twice her then-current
base salary and (z) the aggregate of the annual bonus for which she is then eligible under the agreement and any plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Edward Smolyansky serves as Lifeway&rsquo;s
Chief Operating Officer and is not subject to an employment agreement. Pursuant to the terms of his employment set by the Board,
Mr. Smolyansky is entitled to an annual base salary and is also eligible for certain cash, equity, and other incentive awards based
on the satisfaction of the Board&rsquo;s pre-established performance goals. In each of 2016, 2017, and 2018, Mr. Smolyansky was
entitled to receive an annual base salary of $1,000,000, an amount that the Board reviews annually. In 2017 and 2018, the Board
has set bonus targets in compliance with its Omnibus Plan and applicable IRS regulations governing performance-based compensation.
Mr. Smolyansky is not subject to any severance or change-in-control arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">John Waldron serves Lifeway pursuant to
an employment agreement dated as of April 21, 2017. The agreement renews automatically for successive terms of one year on January
1, unless pursuant to the agreement it is terminated earlier or the Board gives timely notice of non-renewal. Mr. Waldron&rsquo;s
base salary was $325,000 in 2016, $400,000 in 2017, and $410,800 in 2018. His base salary is subject to annual review by the Board.
Pursuant to the agreement, Mr. Waldron is also eligible for certain cash, equity, and other incentive awards based on the satisfaction
of the Board&rsquo;s pre-established performance goals. In 2017 and 2018, the Board has set bonus targets in compliance with its
Omnibus Plan and applicable IRS regulations governing performance-based compensation. Lifeway may terminate Mr. Waldron&rsquo;s
employment for any lawful reason, with or without Cause, and Mr. Waldron may resign for or without Good Reason (each as defined
in the agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to his employment agreement, Mr.
Waldron, upon Non-Renewal, termination without Cause, or by his resignation with Good Reason (each as defined in the employment
agreement), will be entitled to certain payments and benefits shown in the tables below. Receipt of any severance amounts under
Mr. Waldron&rsquo;s employment agreement is conditioned on execution of an enforceable general release of claims in a form satisfactory
to Lifeway.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="7" STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>John Waldron: Summary of payments and benefits due after
        termination of employment</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 5%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Non-Renewal</B></FONT></TD>
    <TD STYLE="width: 5%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Termination without Cause or for Good Reason</B></FONT></TD>
    <TD STYLE="width: 5%; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 23%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Termination for Cause or Without Good Reason</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Base Salary</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">3 months after termination date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">The remainder of the term or 6 months, whichever is greater</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Through termination date</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Bonus Payments</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Greater of (i) bonus for fiscal year of termination date (ii) bonus paid for fiscal year prior to termination date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Greater of (i) bonus for fiscal year of termination date (ii) bonus paid for fiscal year prior to termination date</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">None</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Outstanding Equity Awards</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Vested but unsettled outstanding equity awards</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Accelerated vesting of all outstanding equity awards</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Vested but unsettled outstanding equity awards</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Health Insurance</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">None</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Company-paid COBRA premiums through the earliest of (i) six calendar months after termination date, (ii) the date executive becomes eligible for group health insurance through another employer, or (iii) the date executive ceases to be eligible for COBRA coverage</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">None</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(238,238,238)">
    <TD><FONT STYLE="font-size: 10pt">Financial Services or Transition-Related</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">None</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$10,000</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">None</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Omnibus Plan Change of Control Provisions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Articles 16.1 and 16.2 of the Omnibus Plan, if,
prior to the vesting date of an Award under the Omnibus Plan, a Change of Control occurs and the NEO receives neither (i) a Replacement
Award nor (ii) payment for the cancellation and termination of the Award, then all then-outstanding and unvested Stock Options,
Stock Appreciation Rights, and Awards whose vesting depends merely on the satisfaction of a service obligation by the NEO shall
vest in full and be free of vesting restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Article 16.3 of the Omnibus Plan, upon an NEO&rsquo;s
termination of employment other than for Cause in connection with or within two years after a Change of Control, then (i) all Replacement
Awards shall become fully vested and (if applicable) exercisable and free of restrictions, and (ii) all Stock Options and Stock
Appreciation Rights held by the NEO on the date of termination that were held on the date of the Change of Control shall remain
exercisable for the term of the Stock Option or Stock Appreciation Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capitalized terms used in this section but not defined herein
have the meanings assigned to them in the Omnibus Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no other agreements with the NEOs that provide for
payments in connection with resignation, retirement, termination of employment, or change in control other than the employment
agreements described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Equity Compensation Plans</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain information, as of December
31, 2017, regarding the shares of Lifeway&rsquo;s Common Stock authorized for issuance under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Plan category</B></FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(a)</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Number of securities to be issued upon exercise of outstanding options, warrants and rights</B></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(b)</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Weighted-average exercise price of outstanding options, warrants and rights</B></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(c)</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Number of securities remaining available for</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>future issuance under equity compensation plans (excluding securities reflected in column (a))</B></P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 49%; text-align: left">Equity compensation plans approved by security holders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: center">47,000</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: center">$10.45</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: center">3,485,038</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Equity compensation plans not approved by security holders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">0</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$0</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&mdash;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">47,000</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">$10.45</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">3,485,038</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 29, 2016, Lifeway filed a registration
statement on Form S-8 with the Securities and Exchange Commission in connection with the Plan covering 3,500,000 shares of its
Common Stock, as adjusted. The Plan was adopted by the Company on December 14, 2015. Pursuant to such Plan, we may issue common
stock, options to purchase common stock, stock appreciation rights, restricted stock, restricted stock units, performance units,
performance shares, cash based awards and other stock based awards to our employees. There were a total of 3,483,038 shares eligible
for issuance under the Plan at December 31, 2017. The option price, number of shares, grant date, and vesting terms of awards granted
under the Plan are determined at the discretion of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Outstanding Equity Awards at December 31, 2017</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth information regarding outstanding
equity awards held by our named executive officers at December 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="9" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option Awards</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number
    of<BR>
 Securities</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>Underlying Unexercised</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>Options
    Exercisable<SUP>(1)</SUP></B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number
    of<BR>
 Securities</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>Underlying Unexercised</B></FONT><BR> <FONT STYLE="font-size: 10pt"><B>Options<BR>

    Unexercisable<SUP>(1)</SUP></B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option<BR>
Exercise <BR>
Price</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option<BR> Expiration<BR>
 Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%; text-align: left; padding-top: 3pt">John Waldron</TD><TD STYLE="width: 2%; padding-top: 3pt">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: center; padding-top: 3pt">2,000<SUP>(2)</SUP></TD><TD STYLE="width: 2%; padding-top: 3pt">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: center; padding-top: 3pt">4,000</TD><TD STYLE="width: 2%; padding-top: 3pt">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: center; padding-top: 3pt">$11.10</TD><TD STYLE="width: 2%; padding-top: 3pt">&nbsp;</TD>
    <TD STYLE="width: 13%; padding-top: 3pt; text-align: center">01/01/2026</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 0.5in; text-align: left; vertical-align: top">(1)</TD>
    <TD STYLE="text-align: left">Options to Purchase Shares of Common Stock</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; vertical-align: top">(2)</TD>
    <TD STYLE="text-align: left">Of this grant, 2,000 shares vested on January 1, 2017, 1,000 vested on January 1, 2018, and 1,000 vest on January 1 of each of 2018, 2019, 2020 and 2021.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Clawback Policy</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has adopted a specific clawback
policy that provides that it may claw back incentive-based compensation awards. Persons receiving incentive-based compensation
awards are notified that, at the direction of the Board or its Compensation Committee after it has considered the methods, costs,
and benefits of doing so, Lifeway will seek to recover incentive-based compensation awarded or paid for a fiscal period if the
result of a performance measure upon which the award was based or paid is subsequently restated or otherwise adjusted in a manner
that would reduce the size of the award or payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Director Compensation for the Fiscal Year Ended December
31, 2017</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Cash</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Other<BR> Compensation</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 49%; text-align: left">Ludmila Smolyansky</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">1,600,000</TD><TD STYLE="width: 1%; text-align: left">(1)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">1,600,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Renzo Bernardi</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">27,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">27,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Pol Sikar</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">57,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">57,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Mariano Lozano(2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Paul Lee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">113,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">113,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Jason Scher</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">103,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">103,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Laurent Marcel(3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(1) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Of the Fees Paid in Cash, (a) $1,000,000 represents the annual fees paid to Mrs. Smolyansky for her services as a consultant to Lifeway on strategic matters including, without limitation, plans and strategies for geographic expansion, development of recipes and new products, and new product and facility acquisition; and (b) $600,000 represents royalty payments as discussed further in &ldquo;Certain Relationships and Related Party Transactions.&rdquo; Mrs. Smolyansky did not receive any additional retainer fees or other meeting attendance fees in her capacity as a director. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">On November 1, 2017, Mr. Lozano resigned as director effective December 31, 2017.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">On November 1, 2017, the Board appointed Mr. Marcel as director effective January 1, 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING
COMPLIANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 16(a) of the Exchange Act requires
our directors, executive officers, and persons who beneficially own more than 10% of its Common Stock to file reports of ownership
and changes in ownership with the SEC and to furnish us with copies of all such reports they file. Based on our review of the copies
of such forms that we received, or written representations from certain reporting persons, we believe that none of our directors,
executive officers, or persons who beneficially own more than 10% of Lifeway&rsquo;s Common Stock failed to comply with Section
16(a) reporting requirements in the fiscal year ended December 31, 2017, with the exception of a late Form 4 report for Ludmila
Smolyansky. Mrs. Smolyansky filed a Form 4 on December 26, 2017 to report, among other transactions, the sale of 856 shares of
our Common Stock on December 18, 2017 and 109 shares of our Common Stock on December 20, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AUDIT MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Audit Committee Report</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of Directors has the ultimate
authority for effective corporate governance, including oversight of Lifeway&rsquo;s management. The Audit Committee assists the
Board in fulfilling its responsibilities by overseeing, among other things, Lifeway&rsquo;s accounting and financial reporting
processes (including the internal audit function), the audits of Lifeway&rsquo;s consolidated financial statements and internal
control over financial reporting, the qualifications and performance of the independent registered public accounting firm engaged
as Lifeway&rsquo;s independent auditor, and the performance and continued retention of Lifeway&rsquo;s internal auditor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee relies on the expertise
and knowledge of management, the internal auditor, and the independent auditor in carrying out its oversight responsibilities.
Management is responsible for the preparation, presentation, and integrity of Lifeway&rsquo;s consolidated financial statements,
accounting and financial reporting principles, internal control over financial reporting, and disclosure controls and procedures
designed to ensure compliance with accounting standards, applicable laws, and regulations. Together with Lifeway&rsquo;s internal
auditor, management is also responsible for objectively reviewing and evaluating the adequacy, effectiveness, and quality of Lifeway&rsquo;s
system of internal control. Lifeway&rsquo;s independent auditor, Mayer Hoffman McCann (MHM), is responsible for performing an independent
audit of the Company&rsquo;s consolidated financial statements and expressing an opinion on the conformity of those financial statements
with accounting principles generally accepted in the United States. MHM is also responsible for expressing an opinion on the effectiveness
of Lifeway&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During fiscal year 2017, the Audit Committee
fulfilled its responsibilities as set forth in its charter and further described above in &ldquo;Committees of the Board &ndash;
Audit Committee.&rdquo; The Audit Committee has reviewed and discussed with management, and the independent auditor, Lifeway&rsquo;s
audited consolidated financial statements and related footnotes for the fiscal year ended December 31, 2017, and the independent
auditor&rsquo;s report on those financial statements. Management represented to the Audit Committee that Lifeway&rsquo;s consolidated
financial statements were prepared in accordance with accounting principles generally accepted in the United States. MHM presented
the matters required to be discussed with the Audit Committee by Public Company Accounting Oversight Board standards and Rule 2-07
of SEC Regulation S-X. This review included a discussion with management, the internal auditor, and the independent auditor of
the quality (not merely the acceptability) of Lifeway&rsquo;s accounting principles, the reasonableness of significant estimates
and judgments, and the disclosures in Lifeway&rsquo;s consolidated financial statements, including the disclosures relating to
critical accounting policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the reviews and discussions described
above, the Audit Committee recommended to the Board of Directors that the audited consolidated financial statements be included
in Lifeway&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 31, 2017 for filing with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee also recognizes the
importance of maintaining the independence of Lifeway&rsquo;s independent auditor, both in fact and appearance, and takes a number
of measures to ensure independence. With input from management and MHM, the Audit Committee also assesses MHM&rsquo;s performance
and leads the selection of MHM&rsquo;s audit engagement partner. As part of its auditor engagement process, the Audit Committee
consults with management and considers whether to rotate the independent audit firm. MHM has served as Lifeway&rsquo;s independent
auditor since 2015. In addition, MHM has provided the Audit Committee with the written disclosures and letter required by applicable
requirements of the Public Company Accounting Oversight Board regarding the independent accountant&rsquo;s communications with
the Audit Committee concerning independence. The Audit Committee has reviewed these materials and discussed MHM&rsquo;s independence
with the firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the review and discussions
described above, the Audit Committee concluded that the selection of MHM as the independent registered public accounting firm for
fiscal year 2018 is in the best interest of Lifeway and its shareholders. The Committee therefore recommended to the Board that
it have shareholders ratify this selection at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Respectfully Submitted,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>AUDIT COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Paul Lee, Chairperson</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jason Scher</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pol Sikar</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE FOREGOING AUDIT COMMITTEE REPORT SHALL
NOT BE &ldquo;SOLICITING MATERIAL&rdquo; OR BE DEEMED FILED WITH THE SEC, NOR SHALL SUCH INFORMATION BE INCORPORATED BY REFERENCE
INTO ANY FILING UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE EXCHANGE ACT, EXCEPT TO THE EXTENT WE SPECIFICALLY INCORPORATE
IT BY REFERENCE INTO SUCH FILING.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Independent Registered Public Accounting Firms and Fees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth the fees for professional audit
services rendered by our independent registered public accounting firm Mayer Hoffman McCann (MHM) in connection with fiscal years
ended December 31, 2017 and 2016 and fees billed for other services rendered by MHM during those periods:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Type of Fees</B></P></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2016</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; text-align: left">(1) Audit Fees</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">557,564</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">684,278</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">(2) Audit-Related Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">(3) Tax Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">(4) All Other Fees</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">557,564</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">684,278</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the above table, in accordance with the SEC&rsquo;s definitions and rules, &ldquo;audit fees&rdquo; are fees Lifeway paid to
its independent registered public accountant for professional services in connection with the audit of our consolidated financial
statements for the fiscal years ended December 31, 2017 and 2016 included in Form 10-K, for <FONT STYLE="background-color: white">the
audit of our internal control over financial reporting,</FONT> for the review of the unaudited financial statements included in
Form 10-Qs within those fiscal years, and for services that are normally provided by the accountant in connection with statutory
and regulatory filings or engagements; &ldquo;audit-related fees&rdquo; are fees for work performed during those fiscal years for
assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial
statements; &ldquo;tax fees&rdquo; are fees for work performed during those fiscal years for tax compliance, tax advice, and tax
planning; and &ldquo;all other fees&rdquo; are fees for work performed during those fiscal years for any services not included
in the first three categories. All of the services set forth in sections (1) through (4) above were approved by the Audit Committee
in accordance with its charter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fiscal years ended December 31,
2017 and 2016, we retained certain firms other than MHM for tax compliance, tax advice and tax planning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pre-Approval of Audit and Non-Audit Services</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lifeway&rsquo;s Audit Committee has adopted
policies and procedures for pre-approving all non-audit work performed by its auditors. The policy sets forth the procedures and
conditions for both pre-approval of audit-related services to be performed by its auditors (assurance and related services that
are reasonably related to the performance of the auditors&rsquo; review of the financial statements or that are traditionally performed
by the independent auditor) and specific pre-approval for all other services for the current fiscal year consistent with the SEC&rsquo;s
rules on auditor independence. The Audit Committee is asked to pre-approve the engagement of the independent auditor and the projected
fees for audit services for the current fiscal year during the first quarter of each year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless a type of service has received general
pre-approval, it will require specific pre-approval by the Audit Committee if it is to be provided by the auditors. Any proposed
services exceeding pre-approved cost levels or budgeted amounts will also require specific pre-approval by the Audit Committee.
In determining whether to approve a particular audit or permitted non-audit service, the Audit Committee will consider, among other
things, whether the service is consistent with maintaining the independence of the independent registered public accounting firm.
The Audit Committee will also consider whether the independent registered public accounting firm is best positioned to provide
the most effective and efficient service to us and whether the service might be expected to enhance our ability to manage or control
risk or improve audit quality. Specifically, the Audit Committee has not pre-approved the use of MHM for non-audit services. There
was no non-audit work performed by MHM for the fiscal years ended December 31, 2017 or December 31, 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">BY ORDER OF THE BOARD OF DIRECTORS</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><U>/s/ Douglas A. Hass</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Douglas A. Hass</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">General Counsel and Assistant Corporate Secretary</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chicago, Illinois</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0">Date: <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 30, 2018</FONT></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 33%; padding-left: 10pt">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0; margin-left: 0; text-align: left"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif"><B><I>&nbsp;</I></B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0; margin-left: 0; text-align: left"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif"><B><I>&nbsp;</I></B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0; margin-left: 0; text-align: left"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif"><B><I>&nbsp;</I></B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-bottom: 0; margin-left: 0; text-align: left"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif"><B><I>&nbsp;</I></B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><B><I>LIFEWAY
FOODS, INC.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><B><I>ATTN:
LEGAL DEPARTMENT</I></B></FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><B><I>6101
WEST GROSS POINT RD.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><B><I>NILES,
IL 60714</I></B></FONT></P>


&nbsp;</TD>
    <TD STYLE="width: 17%">&nbsp;</TD>
    <TD STYLE="width: 50%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>VOTE BY INTERNET - <FONT STYLE="color: blue">www.proxyvote.com</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">Use the Internet
to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. Eastern Time the day before
the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain
your records and to create an electronic voting instruction form.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt"><B>ELECTRONIC DELIVERY OF FUTURE
PROXY MATERIALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">If you would
like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements,
proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the
instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials
electronically in future years.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>VOTE BY
PHONE - 1-800-690-6903</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">Use any touch-tone
telephone to transmit your voting instructions. Vote by 11:59 P.M. Eastern Time the day before the cut-off date or meeting date.
Have your proxy card in hand when you call and then follow the instructions.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>VOTE BY
MAIL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 8pt">Mark, sign
and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge,
51 Mercedes Way, Edgewood, NY 11717.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 8pt Arial, Helvetica, Sans-Serif"><B></B></FONT></P></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font: 8pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>


<P STYLE="margin-top: 0; text-align: left; margin-bottom: 0"><FONT STYLE="font: 7pt Arial, Helvetica, Sans-Serif">TO
VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:</FONT></P>

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0"><FONT STYLE="font: 7pt Arial, Helvetica, Sans-Serif">KEEP
THIS PORTION FOR YOUR RECORDS</FONT></P>

<P STYLE="margin-top: 0; text-align: left; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt dashed; width: 100%"><FONT STYLE="font: 7pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: right; margin-bottom: 0"><FONT STYLE="font: 7pt Arial, Helvetica, Sans-Serif">DETACH
AND RETURN THIS PORTION ONLY</FONT></P>

<P STYLE="margin-top: 0; text-align: left; margin-bottom: 0"></P>

<P STYLE="font: 10pt/5.95pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>THIS
PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.</B></FONT></P>

<P STYLE="font: 10pt/5.95pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt/5.95pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="image1.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt/5.95pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/5.95pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Annual Report and Proxy Statement are available at <FONT STYLE="color: blue">www.proxyvote.com</FONT></FONT></B></FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt dashed; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>



<P STYLE="margin: 0"></P>

<DIV STYLE="margin: 0.1in; padding: 0.1in; border: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt/11.3pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>LIFEWAY
FOODS, INC.</B><BR>
<B>Annual Meeting of Shareholders</B><BR>
<B>June 14, 2018 2:00 PM</B><BR>
<B>This proxy is solicited by the Board of Directors</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"></FONT>The undersigned, revoking all prior proxies, hereby constitutes and appoints Julie Smolyansky or Edward Smolyansky,
true and lawful agents and proxies with full power of substitution in each, to attend the Annual Meeting of Shareholders of Lifeway
Foods, Inc. to be held at the Holiday Inn, 5300 W. Touhy Avenue, Skokie, Illinois at 2:00 p.m. local time, on June 14, 2018, and
at any adjournments or postponements thereof, to cast on behalf of the undersigned all votes that the undersigned is entitled
to cast at such meeting, and otherwise represent the undersigned at the meeting with all powers possessed by the undersigned if
personally present at the meeting.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE VOTES ENTITLED TO BE CAST BY
THE UNDERSIGNED WILL BE CAST AS INSTRUCTED ON THE REVERSE SIDE HEREOF. IF THIS PROXY IS EXECUTED BUT NO INSTRUCTION IS GIVEN,
THE VOTES ENTITLED TO BE CAST BY THE UNDERSIGNED WILL BE CAST &quot;FOR&quot; PROPOSAL 2. THIS PROXY WILL BE VOTED IN THE DISCRETION
OF THE PROXY HOLDER ON ANY OTHER MATTER THAT MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENTS OR POSTPONEMENTS THEREOF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>



<P STYLE="margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt; text-align: left"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Continued
                                         and to be signed on reverse side</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>

</DIV>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" (/ SL# 2(  A$! Q$!_\0
M'  !  ,! 0$! 0            4&!P0# @$(_\0 6Q   0,# P$#! H,"P<#
M P,% 0(#!  %$082(1,4(C$'%D%4%2,R-5%589&6TR=69W%S=8*2I++1U"0S
M-C="@925M<+2%S12H;&SM ARA"5BP4-%8X-3=/"3_\0 & $! 0$! 0
M          $" P3_Q  X$0 " 0$%!P0#  $# P0#     1$"$B$Q0?!188&1
MH<'1(G&QX0,R\4(3LM)2HL($(S.20V+B_]H # ,!  (1 Q$ /P#^HILMF&P7
M9"MJ!Q\I/P"HD:E8/*8\@CX<#]M?FI4AR;:VE\MK=(4/AY2/_P U/) 2 $@
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M]VUW&(8EB:?EP8S2)C;I*XW1" J.C<TKVIS82<Y&5G*5>G%-U$1DOCMAOC;
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M 5+5DDGNCD\<#X!7E>+QI"XOMOW.5'<79I*7D.+W@-.YZ8((X7WE;?2 K'I
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ME9LN&IU$?96I<ZQTC^;KQY1-4MBW(M6IE28[SS(<F)B,?QB^F'&,;,>UE?\
M[AG"B2*BXGE5URH-2VKAVQ3D=M:80B-;5+,0N<82%>[YQGY/"OZEI52AM[0E
M%*3Q/YW7Y0=42;&J9#O,AIJ)$N$Q#JVH;BI@8$<I"RV%M@;G'$G80<#T'P_'
M-4W.1JFX7$7YOV9AVNY),=QE"46T"4RE"3M03WD)"MRPL?TO<G%?T32J\HR3
M7--3U)9NB<^\E.\F]VG:BT$U+?E.JFK+S29*PTK)2M24K2IL=-8X&%) "O'
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M'/CO-I0VHI22A2=R=Q)#G&U6#D<$UPW+1.FKH($1RX%,M++/9VW@PZLH0TI
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MI/UE43RY>2/1&F/);>[O8[)V6XQNATGNUOKV[GVTGNJ60>ZHCD>FOZ+K+_\
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M\0CU+T I2E 5?2'\H-;_ (X;_P /AU:*J^D/Y0:W_'#?^'PZM% *4I0"E*4
MJK^5/^;'5_XGF?\ 975HJK^5/^;'5_XGF?\ 970%HI2E *4I0"E*4 K+_P#U
M,_S(ZD_^-_Y+5:A67_\ J9_F1U)_\;_R6J ?^F;^9'3?_P G_P EVM0K+_\
MTS?S(Z;_ /D_^2[6H4!4/*I_)%'XTMG_ )S%6.Q^];/Y7ZQJN>53^2*/QI;/
M_.8J=L[Q1;F4])Q6,\@<>)K-5:H4LJ3>!UZ@]\[/^&_S)J=J"U![YV?\-_F3
M4[6B"E*H.OH3BM<:%FF;(Z2;BIH1 0&BHQWR5GC)5P .<#GX:*]I#)O8F^1?
MJ5X19D>4N0B,\VZJ.YTG0DYV+P#M/P'!!_KK\N7O=*_!+_Z&LUU6:75NDM*M
M.#HI6&Z:;L4WR6QEP+=I-M^-+MRU&S2&Y"@YU6AO=(;04.D%0(Y/CR:E[WK.
M_P 75=^AP@\ZY&9D%F&6V2@(1'"VW D'K$E?&2-A! '(YW4K-3I]^D>3%-5J
ME5;7!K=*R95Z6ZYI^4WKB5)M2+NIAZ<EMAEIQ)BJ4$+6$;'!OPG( &3MQO3N
MJ4O<Z9:)>I7$7-;*3(@A<U;+15$9<60LY" "$I)P5A6/$Y -2KTQO^O(M:Y^
M#1:5D*-2WYYF'*9O3JH[.S!2PR4SVU3^BEQ1V<!37/<V@DY''%77R@7-ZV0+
M>I-R]B8C\Q+4JX8;_@S>Q9!RX"@94E"<J!'>^'%1N*;6^.L&E>VMGB2TTK+[
M6S(O^K=%7"[27''!:)$H,JCM!!<2XP X$J05()"L\$$< $#.>_RKBQ&181JC
ML?8>I(V=JV_QO15LV9__ %,^YQWL^%*W8HM/?T;78B<OEU-!I69V5V[0E7!R
M?+=-Q3IF,^HK:;W,O .Y .S)&Y.<+*N2?O5&:SU'J'3-KLI3=YLIR9'=DA\L
MQ$;WPEOIQ^\$@H45+.U&72!W<X-:CUV-9^&$YA;?"?<U^E9,Y?KI=(.J&4Z@
MEL75N+.5[&1HR.I"Z2\,J"PG<DK1@X7N*MV4%.VOJ5JN0V_:46_4PDLJC1E1
M<!AWV5=4^4/()2GDH2!_%[2G=E6<5$IC?'6?&4EJN4^_2/)J]*RRXW2_0M%R
M;PO4JTNO3E,I#Z8[#;#:9"T80X65!*BD ;G,ISZ4YXOVDYSESTQ:ISQ<+LB*
MVZHNMAM1)2"24@D _("12EVDVLNZDDX;R5I2E"BE*4 I2E *4I0"E*4 I2E
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ME*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
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M.A 0E2UC+:D>Z1@)'>[V03X*%7*ZNK8M<QYI6UQME:TG&<$))%9_*U_I7_\
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M>6\4/!.$^"4@'VLC;NRK(%2OEJ5$18[.JXLVA^(+DCJ-WAX,Q%>U.XZJRE0
MS@CNGG X\1H5*S4K2C?/6==(%-W*.D3W,2TYJJ[1)&E+6R[*2PJ'#;0T4L;9
M 5N2ZX=ZNJH)"04EL$ #*N#Q+,3-1NZ2TU*5JB<)5T:,EYT18N48C+<V('2P
M$E03X@G@\C-:O2E4U*J^]O'89I343NZ>3&96N;L=1M1V;KT]\0[XQ2PG:KL)
M>#B$%)</?QWRH)\4[3@JK]\H4ZXP](B)==2O]&?:I$CJ/,L(,E[:V$Q@0@
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M(.Y0 PH'.*E=579VRV-V=&C(E/!;3;;2W2TE2G'$H&5A*B!E0).T_>H[BJ_
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M(& /O 5]K9:6G"VD*'P%(/RU2!J[45SF3O-?3,.? B27(9D2[KV92W&SM7A
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MXU@G\,Y6U$^W5M=BYTK--:HNLW7:(EI1>''6X4=UI<6X&/'C*+Z]RWF^HD.
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MY\:TZ6G&L&S,IQ&_I'DM]*K/D^+@L\UIQ^0^&;C+90J0\MY80EY02-RR5'
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M/143[:"[@<Y ;&00,CFON+K:_J?9>?3:S"9##<EMN.X''5K6\@E"BYA '2!
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MWLE_@5_JFH:Q^];/Y7ZQJ9NGO9+_  *_U34-8_>MG\K]8T!ZZ@]\[/\ AO\
M,FIVH+4'OG9_PW^9-3M *JE^D0_.ZVVR3IM-P5/84M4U262&PRM*D@A1W$)4
MO=\A((R<XM=436MTBQ=4VU2F+V'[>V'GI4 1RTVRZL(*70Z=Q22WSTTE0 \1
M4S0=U+;P(FP:ELGL9+9?TF&9T]:%.Q8\2.E-R4M;B0I.5X5_%K)ZA2<#/A5L
MB0--7=,75:;) <FED/-RW8;?:4 #PW$;@1R,9XJK7*QZ$G09+<G4<(MP6V67
MEKEQG!'*7'"DK2M)1DEQ:<+!!^#(S5JM3EA@6!NS6JYP"VRPIIM/:$$X" HD
M@? %I4<# "@<8(K#;7XVUBL.0CUI/!_-TZYD/;M<6UJ!%-NT[=&GISZ"U!:9
M80XLO-K>#A]L" %!"R259R#D5T2]3VMV1/0_8)KY6PXPXHQV5=J+:"M<?E>5
M$!2^% ))W $UXZ/TG BQK47;P[<KE!3'?4X'VUC 86TA(VI'M>%N%)(R?$DU
MQR+=;;CJ*YQP[J!B*I4A!DMEI,6.^IH!U2%8+B5;">\KN DXYKI^2ZIJG?TC
M'6,'.BIV::GG$\WATZG?&U';;C;[3<K5:%F!=+@@)E.1FPE1!"$ND%85E02
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M )P E9VG@CW6>/15NM.<,N9I393SS98YC"&=8VR&U#M28LJ&XXA8A#K-.,;
MV0O=C #IP-O'.#S3R6L.Q=,.Q9+J)$AB?+;=D);Z9?6'U[G"G) *CDD#CG@
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M]!?[1;H2C*84$!Q&U325)1_1 X*LD$@$G(%:_)?4[.V[GK^BB(5KC[1?TO\
MHG)FIHG4U BZPU>QELA,S2AQE"NHA1<.\'>01[6,!02002?$8]+%;=,ZBM,.
M<C3EO2R@JZ"7HK"]F,)R@HW)P0E."DD$ ?!7BI%C5<=1 71R.IJWL1IDE$MI
M"8Z$%W:<@[D+&Y1)4 /<X]-?NF)NE-.V1A$345M<BS9#BVY#DIA(D.E7>"=@
M2@G.!A(_YFI=:<87&;X4\>1-'35B+DUPV6V%<T8E*,1O+XSG"SCO<\\YKJ:M
M<%E4,L16FA#241TMIV):20 0$C@# '%=E*;C<9BE*4 I2E *4I0"E*4 I2E
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MZ\0M)JF,*OLF7(N*Q,:7.EA8CAYS:&P@+6V,=/EM&2GYZ^+-YQ*F6<707P7
MB*$[5/=GZ&%=8ND (ZF/^,!6=N .:Q"J5G>OCX^]A*JH6&3Y7]<>:X>UNTY(
M#[2K)*L%PF6QEB*]$5();0I,=;*@O:A12<G@%/(!!Q79;]$7>-K:/<ESHWL8
MAY$M33(2C#B8HC[$M],D)XR#U< '&S/>J5\GD 6#3<A+[5Q0IRY2NX\IY]>%
M2G A0"MQ"2"E14.,'<3XFKC77"IU9O'7O>2C\:IILK"]:X&7>5GR;S]:7JVS
M+?.9BMQVNF\E:E N=]/P).1TUR$_?6/OBUW'3S\M&IVTNM-HND-,9D\DH(;6
MG*ACP[P\*LU*S'IL97]3K/K5>:[%#GZ7N]U;9=F(MT>4F/&94AM];J06I*72
M0HMI/*4_!X\>'-6;5=O?NNG9\*&IH27F\-]4D(W Y ) ) X\<'[U2U*KO4>_
M4PJ4KM81\(I%STO<KK->F2.Q17WS#*@TZISI](N;L**$D_Q@QP/3X5$V'0EY
MAV&7#FS8[KZUP4-=\% ;CN)5GNM(P2 0!A1&!E9\1IM*E*LMM9N>1+"E59HB
M+=:E1K]=Y[H94F6IHMD<J3L1M.>/E.,?#7%K-:G%6>&RQ*=><N$=W+4=:T)0
MVXE2BM8&U''_ !$9]&:LE*)0UN:?)R::3I=.U/J9=*T-?7YTA6ZV=G97(>B$
MON;GE.S6I00ZGIX0GVO82"KQSCT5 733VH+?<1'5:X\E^[2VG73'#SK49*9Z
MG^ZYTMN=J^]OZ?N04[CQ6X4JJZ%L_IIMM5)YN>)CML\F-[@VQ3;4R"W*0F(I
MM32S@K9Z><E32@.4'!*5>CBIVP:%N-O#"I,B*Z\EV*ZM>[)]K=>6L A"1_\
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MI&  /  5]4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
M*4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4
M I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I
M0"E*4 I2E *4I0"E*4 I2E *4I0'-=/>R7^!7^J:AK'[UL_E?K&IFZ>]DO\
M K_5-0UC]ZV?ROUC0'KJ#WSL_P"&_P R:G:@M0>^=G_#?YDU.T I2E *4I0"
ME*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
M*4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4
M I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I
M0"E*4 I2E *4I0"E*4 I2E *4I0'-=/>R7^!7^J:AK'[UL_E?K&IFZ>]DO\
M K_5-0UC]ZV?ROUC0'KJ#WSL_P"&_P R:G:@M0>^=G_#?YDU.T I2E *4I0"
ME*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
M*4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4
M I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I
M0"E*4 I2E *4I0"E*4 I2E *4I0'-=/>R7^!7^J:AK'[UL_E?K&IFZ>]DO\
M K_5-0UC]ZV?ROUC0'KJ#WSL_P"&_P R:G:@M0>^=G_#?YDU.T I2E *4I0"
ME*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
M*4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4
M I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I
M0"E*4 I2E *4I0"E*4 I2E *4I0'-=/>R7^!7^J:AK'[UL_E?K&IFZ>]DO\
M K_5-0UC]ZV?ROUC0'KJ#WSL_P"&_P R:G:@M0>^=G_#?YDU.T I2E *4I0"
ME*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
M*4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4
M I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I
M0"E*4 I2E *4I0"E*4 I2E *4I0'-=/>R7^!7^J:AK'[UL_E?K&IFZ>]DO\
M K_5-0UC]ZV?ROUC0'KJ#WSL_P"&_P R:G:@M0>^=G_#?YDU.T I2E *4I0"
ME*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
M*4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4
M I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I
M0"E*4 I2E *4I0"E*4 I2E *4I0'-=/>R7^!7^J:AK'[UL_E?K&IFZ>]DO\
M K_5-0UC]ZV?ROUC0'KJ#WSL_P"&_P R:G:@M0>^=G_#?YDU.T I2E *4I0"
ME*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
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MEJZYV;\M=/N$XS@+Y ^_17QK+R5HM-*SYC3MS9U(FZ)$OJKO:UK)EDH$,LD
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ME*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
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MML*64)?!*<+2#WOZ1[OB2G SD58(UMM,2UN6N/#A,VYM!2N(AM(:2E6204>
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M)+X6 %,H)]K0G"TY 2%9\#C-7ZL]T>]IU&MI\*V:*=LMV;8+KTPQ(R I"E\
MK:6I0*B-P"@,@$TI_;F'@:%2E* 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4
MH!4+H+W[UQ^.F_\ #X=350N@O?O7'XZ;_P /AT!9[I[V2_P*_P!4U#6/WK9_
M*_6-3-T][)?X%?ZIJ&L?O6S^5^L: ^)Q6I6GBZI]3A*2HOI2EPGN9W!. %?"
M!Q5EJMW#=U-/[R^5;DY+^.IG*/=8XW?#CC-62K5BR4X(4I2H44I2@%*4H!2E
M* 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* 4I2@%*
M4H!2E* 4I2@%*4H!2E* 4I2@%*4H!2E* 51/)_[R3OQU=?\ $)%7NJ)Y/_>2
M=^.KK_B$B@++2E* 4I2@%>;Y<2PX6$I6\$DH2M6T%6. 3@X'RX->E>,Q3*8C
MZI*PVP$*+BRO:$IQR<^CCTU'@58E$A::ODCR8WK3]T9MS$Z4F4AHLR5NMD.J
M4H;B6TD8*R. >!GTXKN\RV3'U+!0W'C6ZYQVFFD1QMZ:TME)7@  '.T@C_A%
M5O2-[CP/(_?+KIZXIGR8AF.!QZ6N6$K2I73"BI1.-@0<9'!SZ<U/(NNH6X6I
MHJ7HLRZ6YEJ1'6ECII<*D%1;*<GTI(!SZ1\%:KSFXS1_C&^#D8T;=Y6@[Q"N
MTJ+YP75T/R76E*+*BDI"49(SM*$!)X])X-?<+1\IO0=RMCD&*B7,?[0J-VY:
MVL@I/#@:3M/<!X01GQ!R:\FM;3Y^A;WJ>UM-.1 X$VX*0?XL;4K=7R,@*+A]
M'":_8&J[F]Y/;E=S<+,X\R_TX\U#R%L*1E()6I)* H94/';D G'-'-_LNWT5
M8*-K.F/I"=(\FEST_<C!$N4E\-E*$E""LDI*BE" I63DJ"!S\YZ;G8KC/L-E
M!M]K9E0)0DN6U+Y,9T +3MW],?\ $%CN>Z ^_41+OMSO?D@O-RMT]UJXLM2
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MM+K'1/N9=2I</9)HM*SE[RC2XFF;7=[C:K;#]D\+BI>NP0WLZ96=[BF@$JX
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M0"MP@%6,D^/'%@JCZXTF=17ZUK-XCQND4.HB/,EU2BTZEPK;]L2 3W4J)2K
M(QCTY7[+9G[%>#UF<,V]Z4E6*Z7!ZW7L,+NJ4/EN+*;>,D*2R'$%.%)P$ =T
MCX"-RL'V;@:(:U+"80U(;N380IILF4EH+Z2MH6#[7UNENX7[84U[/6,FU7^
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M!5JNF;KS"6%Y]75=U=\G]BF7:-*=G1Y425+;:8*W=B'4E2NF@9*MHR4I'CG
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MC%"4H5E+B"5X!0H*;_IY"CBH5S7ES3I-I]G4ID+=0R1/"8K0#ZHZUN,E2D%
MVJ"3M"%+.=ORB\6-^\7R3-?5?9<=AN)'4B/'98V[G(X45;E(*L[B".<??'AK
M\E5EU3_C=T^C'X?R+TM9W\FBJ730EP9<N,>!I]IV I3R;:VTXTA$)Y;,8)DA
M)4-NU:'3E/?!R0#N)JP:9LEYBZH<,RW.-Q8[=R"99=:*'S(DH=1M 45#NI.=
MR1S5:3J.\-:)L3]NU/)??CV.5.EK4EAY;C[*6#T7"4$C!6H'P7SR<\UZG6VH
M'I^J&&Y3S+L6/,4$J;CJ3#4VZE+"DI!+G?02H]485P4<5TKI:BC=5\-/O'\'
MZT3E*>N_2]L]9NCKLNWZ::D6/MS\6!;6$+ZK/_T]UEY*GE94H>Z2 ,HW9V8\
M,5>_*/;)UVTPN-;&6I#O7:<7'=2%I>;2L%2"DK0% @>Y*D@^!/-5G4]WN^F]
M0:=@JO[\MI]8#J7$1TOO[GDI]QTDA:0%$$-J2I/NB%"H:VO7-&CK_!-VD+CH
MLBIS*5,,'I$K?!;&6R%((0D'=N/CR,UBJJVIWM\4Y>N9TI5JJSN2YQ2CR9T?
MJ7V1L"G+8E#L1+>V6V&!V=.YW*,J<4M 2E:1M;R"/%2L 5VL:&5.@0HLK24>
M*PR2I]#KS;@D/"*XCK%(44\K4G"CWB>5 8%2LC44QC6T.W-7<)RU!Z=K#3?M
MR'"X'7,[=_="0>" -O/C6BQY#,E"EQGFWD)6ILJ;4% *22%)X]((((]!%9="
M=-2VMZ1PHLU.FI9)=]>Q#.P)3NAE6]QM:YBK=T%(#_345]/:1U,':<_TL''C
MS5-TOI.8Q8K4B59F&),*[)?8W-L(=:9.W>HAM1;220<AL@* !QDD5[&^R97E
M'G6-ZXMRXRIG97+0XTTI*8IAAPNGN[R.H0G))3WL8\*KMYU)<=+Z5L#%G4Y%
M84W,4WT4,!+CR'<-,'JD#:H%7=;]L.WN^!K4S6JLZH?)VM<L3?\ IW+\6Q/J
MHUX.&/:V[WJ>]6V+;67IP8EMW!\.MJ,H+FMJ0%][>G#:5 !83P"$Y !K6-$6
MIRRVB3#7&1%:3-DK891MVI:4ZI2 D#@#!''H^ 5G*];W=V[ZC88O#;(9B2G&
MVY/1'9%M/(0"4H0I:!A1[SF_/"]J4\5Y#7M[*;$&Y4I9>)"3B(1-6));4DG(
MWI"!D*8 )W!12!Q4H_6FE9J.K\,-I6JGD^T=\[^1Y6G35TN&F)#EILK<9AWH
M]5ETMK3<BB2M:U%L.)!!20,+4@J]R< #-ET=HI]FX-S;_:XSDF/;66HKA"<L
M.!Z0K8C"E%!2A;8R"1C@%6*L_E$N$NUZ6D2K?+:AOI<:'6=4$)"2M(4-ZD+2
M@D9 4I)2"><#FJS NL^7*TU=$O/2GI%FEN)9>99&7$=+"@4#/>)YVJVD8( K
M"BFBI;/#U]&E3-<9M?#7@K]IT9=HMH$>=IPSH3;RBF$M49+BUEC:EU>U8:7M
M4/=X2LYW%.1SUR=$7IJ3(N#-N8DW=:RVJ4IU*5/->QG2P5A06$E\#C(.>]QX
MUS0M2WBYN&-;=8O2$;DJ7)9CQBIM79''%,_Q92,+2G.05#P)SS6L6MUZXZ=B
M/+>4S(DQ4++K03E"E(!W)!!'!/I!'R5M?Y^R3^N6KC'XJJ936_Y7T4'1VF;K
M LO9G+:J(A-[9EMLD,-A+(0WN4$-**$]X*X!SZ>2<GZ\I4*5#&I+VDMLJ;B0
M'+<XM8'5E,O/+#0&<Y45H3CT[\"HNY7F\V[35N5;KJY%[/;;E.=V1V/X0MAU
M 2% HP =RL[ G.?16GZA2X[IVX!I]R.X8RR'6MNY)VD\;@1_RJ5U6?Q6^/*%
M_P"/,U^.A-K?Y;[W[CFTM =LNG[3;EMN/.I: ?>!3@.$%2UJR0>5$^ /)^#F
MN+RBVB=?[&Q:X"6PF1+9[0XZD+0AI"MYW(W)*DDH"2D')W??-4=J[#1=EL5J
MB7!F*)<2&N.VMEAM3SKDE ="4I0D*.Q6#@9QR>>:D)EM@G2WE/B&%&[*B0\X
MAGI)V)5V)E6X)Q@'=SGX>:W72JFWDI_[:DH]K^0_!ZK-*SA<U<]9DGI&QWB"
MO2R+BSQ:HDN$X[O2=R=[:6E8"B>\A&?3CTX-6'2$"3;X4YN8WTUNW"4^@;@<
MH6\I23P?2"#CQKM96XU8FW&4;W41@I"?^(A/ K,FM6/KL\1QS691'>=;$VX=
ME82(*RPM99WE/3'?2D84DJ3G:22H$*ZH;G+NR4U312MM_)?>KSTU7HFYS;[=
M[E;(#2)TJ6XE,L.)0M4<V_IA.\'<$EX 8\<][&!FI6R:>FL0-L>T>Q40WIF6
MQ;M[0[,RE* LX0HH&5)6K"2?=?"34:B]:CD:;OMZ>NTB&_!M")*88C,[$NJB
ME9)W(*N%X(&?00<C@14O6MT1%D*CZEZD5E+ZH$T,LGV3?2VP4Q\[-IRMQU.$
M +.W@Y2<DO59S4?]K^O!:XKI53SE=([XKC<C[O>C;W(O%R=AV8"6XF;U+DIQ
MHB8VX\TMMG&\+.&TJ;PK:!C (!S4OI#0[G;K8]J*SPRS%;DKCLEI 1$4I]"V
MTH;"W @@!1&U2@D' /HKJN%SNT6%JN[/WR6S'A/&,S&1'C[& 4-'?N4G.05J
M[RE;0.2#CF%TKJ2;<;CIB===2NLQ7GI\7"7F.A*6AY(:25!L)6I2<@%.,XRG
M&23G\:OI:R2ZIQQOR%;7Y$V]KYJ_E<6+0-AN-HU3?GY$$L0Y2E+2ZZ6E+<47
M5J&%MG*TX5D=1(4G.W*@*@]6Z(N5R\I*+U&MK:VT[ F45H"D@*8^$[N$A[T>
MD_#S*>3[5%TO&J[I"GK?6VT'5+:6E@)C*2\4H2D()< *.?;0"2,IX-=%]O\
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M1?X\?AO6\E5TQN^4M;MQ9Z4I0"E*4 I2E *4I0"E*4 I2E *4I0"E*4 I2E
M*4I0"H707OWKC\=-_P"'PZFJA=!>_>N/QTW_ (?#H"SW3WLE_@5_JFH:Q^];
M/Y7ZQJ9NGO9+_ K_ %34-8_>MG\K]8T!P15MKM6D%L1C$94TT41R22T,-X3S
MSQX5<:J#ZG56_32G9B);Q;052FP-KJL([X]&#XU,;I/KCWYJ/]-;_)^S,T?J
MB7JKZCU1(L]Y;BMVY$B(EE#TA_M&Q3:5NAL;4;3NQG)[PX'PU([I/KCWYJ/]
M-5^ZZ78NVH(]TN$J2ZJ.TE#;05M3E*]X*@G"5@$)("@<$ USOM+9GR?>"O\
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M?Z:;I/KCWYJ/]- =]QA1[E;Y,&:WU(LEM3+J-Q3N0H8(R.1P?17NE(2D)2,
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M#=]5VNU7,VZ2+B[,2RB0IN';9,K8A:EI25%IM0&2VO )SW34]57M_P#.=?\
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MBE <MJGQKK;(=Q@.=6'+91(9<VE.]"TA23@@$9!'!&:ZJJ_DL_FQTA^)X?\
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M/_5-=- *J^K_ .4&B/QPY_A\RK157U?_ "@T1^.'/\/F4!:*4I0"E*4 I2E
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M*S]FC[G?Z;3[-'W._P!-J >NUG1%ALR;NTRRF[QD)>CWQQR,ZA21O"%E05X
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M!(PFV. ? &U?LJV4H"J=MN/Q<[^8K]E?B9=P3G;;'!DY.&U<GYJME* J9EW
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LUTH"GR7[D^RIH07FPK@GIJ/'S58K1%2Q;(S:D=[8"H*'()Y(_P"==U* _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
